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Abstract 
The ultimate aim of this work is to design and engineer an integrated tissue 
engineering approach that combines microenvironmental scaffold cues with soluble 
factor cues so as to enhance cell-instruction and tissue regeneration.  In order for this aim 
to be accomplished, we started off by separately examining the control of 
microenvironmental cues and the regulation of soluble factor cues both in vitro and in 
vivo.   
In the earlier parts of the research, we modified the microenvironmental scaffold 
cues of collagen-based scaffolds through various approaches.  These approaches included 
(i) covalent cross-linking of collagen scaffolds to increase their bulk stiffness (chapter 4), 
(ii) enzymatic degradation of covalently cross-linked collagen scaffolds to decrease their 
bulk stiffness (chapter 5), and (iii) regulation of collagen fiber structure and rigidity 
through control of the thermodynamic driving force for collagen self-assembly (chapter 
6).  Through the various modifications, we were able to generate a range of stiffness in 
the physiologically relevant range and further regulate the malignancy of hepatocellular 
carcinoma cells and fibroblasts with these cell-instructive scaffolds.     
In the later part of this research, we fabricated stiff and metastable poly(ethylene 
glycol diacrylate)-polyethylenimine hydrogels for the release of cytokines in vivo 
(chapter 7).  The high stiffness of the material, attained from the highly branched 
architecture of polyethylenimine, allowed the hydrogel to release encapsulated substances 
independent of local tissue pressures.  The decoupled control of stiffness and degradation 
rate was also achieved by tuning the relative numbers of acrylate and protonated amine 
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groups in the fabricated hydrogels.  Following synthesis, the hydrogels were extensively 
characterized in terms of their mechanical properties, degradation, cytotoxicity, in vitro 
and in vivo drug release.  This hydrogel system was also successfully used as an 
injectable depot for the controlled release of granulocyte colony stimulating factor in 
porcine models.  Although the hydrogel system was only tested with bovine serum 
albumin and granulocyte colony stimulating factor, we expect this customizable and user-
friendly platform to be readily applied to other cytokines. 
The separate investigations of microenvironmental scaffold cues and soluble 
factors cues covered in this thesis would provide an important stepping stone for the 
subsequent combination of these cues in integrated tissue regeneration and cell-
instructive applications.  As this research only serves as groundwork in the proposed 
integrated strategy, new issues and challenges are expected to arise.  This area will be 
examined by other members of the laboratories.   
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1 Introduction 
The motivation, hypotheses and the objectives for this work will be presented in this 
chapter. 
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1.1 Motivation 
Integrated tissue regeneration and engineering approaches which combine 
appropriate scaffold cues with tailored release of soluble factors show great potential in 
the area of regenerative medicine.  However, the design and implementation of such 
integrated approaches remained hindered by numerous challenges in the respective areas 
of scaffold fabrication and controlled delivery vehicle design.  While there had been 
ample evidence highlighting the importance of microenvironmental cues on cell 
phenotypes and activities, the reproduction of such cues in a three dimensional context 
still posed a challenge due to various confounding requirements in the tissue culture 
scaffolds.  This had motivated our efforts to address some of the issues in scaffold design 
and to fabricate novel scaffolds.  In overcoming some of the challenges and successfully 
recapitulating various microenvironmental cues, greater control of cell phenotypes would 
be enabled.   
On top of the microenvironmental cues, this study further looked into the design 
of tailored controlled release vehicles to enable better regulation of local soluble cues.  
Through the customization of both scaffold and soluble cues, we aimed to achieve greater 
control of key cellular events for different tissue engineering applications. 
1.2 Hypotheses    
The key hypotheses in this work are defined as such: 
1) To meet the specialized requirements of cell-instructive tissue engineering 
scaffolds, we hypothesized that collagen hydrogels can be imparted with suitable 
mechanical and structural cues for cell-instruction. 
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2) These cues can be introduced through different means i.e. chemical modification, 
enzymatic degradation, and tuning the thermodynamic driving force for collagen 
self-assembly. 
3) The modified scaffolds, presenting key attributes required for cell instruction, can 
be further used to direct specific cell activities and phenotypes in different cell 
types. 
4) It was further hypothesized that hydrogels can be imparted with specific material 
properties to allow optimal control of soluble factor release in vivo.  The 
hydrogels should ideally be rigid to prevent deformation and uncontrolled drug 
release due to local tissue pressures, but degrade at a controllable rate to ensure 
sustained drug release during the therapeutic window. 
1.3 Objectives 
To investigate the above hypotheses, we devised the following objectives: 
1) Design and characterize chemically-modified collagen hydrogels with tunable 
stiffness: 
a) Formulate collagen hydrogels with different stiffness 
b) Investigate material properties of the chemically-modified collagen 
hydrogels 
2) Investigate effect of increasing stiffness on malignancy of a model cell line 
(hepatocellular carcinoma): 
a) Investigate effect of increasing stiffness on cell morphology 
b) Investigate effect of increasing stiffness on cell function 
c) Investigate effect of increasing stiffness on in vivo angiogenic activities 
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3) Decrease stiffness of chemically cross-linked collagen hydrogels through 
enzymatic degradation: 
a) Decrease stiffness of cross-linked collagen hydrogel through degradation 
by matrix metalloproteinases  
b) Investigate material properties of the degraded hydrogels 
4) Investigate effect of decreasing stiffness on malignancy of a model cell line 
(hepatocellular carcinoma): 
a) Investigate effect of decreasing stiffness on cell morphology 
b) Investigate effect of decreasing stiffness on cell function 
5) Design and characterize structurally- and mechanically-modified collagen 
hydrogels generated by varying thermodynamic driving force during collagen 
self-assembly: 
a) Formulate collagen hydrogels with different structural and mechanical 
properties by varying thermodynamic driving force 
b) Investigate material properties of the structurally- and mechanically-
modified collagen hydrogels  
6) Investigate effect of varying structural and mechanical properties on phenotype of 
model cell line (fibroblasts): 
a) Investigate effect of varying structural and mechanical properties on cell 
morphology 
b) Investigate effect of varying structural and mechanical properties on cell 
function 
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7) Design and characterize poly(ethylene glycol diacrylate)-polyethylenimine hydrogels 
with tunable mechanical and drug release properties 
a) Formulate hydrogels with different mechanical and drug release properties  
b) Testing material properties of hydrogels in vitro 
c) Testing material properties of hydrogels in vivo 
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2 Literature review 
This chapter describes the promise and issues faced in tissue engineering and tissue 
regeneration, with specific focus placed on cell-instructive scaffolds and controlled 
delivery vehicles. 
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2.1 Tissue engineering approaches 
Annually, millions of people suffer from loss of organ function due to accidents 
and organ failure.  However, the mainstream method of treatment, organ transplant, is 
greatly limited by the shortage of available donor organs.  In view of this shortage, tissue 
engineering and tissue regeneration have emerged as promising alternative strategies.[1, 2]  
Tissue engineering involves the engineering and repair of tissues and organs.[2]  An 
overview of the main features in engineered tissues is presented in the following figure 
(Fig. 2.1).  The general approach in tissue engineering involves the harvesting of cells 
from a donor.  These cells are usually expanded in vitro to generate more cells or 
differentiated through exposure to specific cytokines to yield desired cell types.  These 
cells are then combined with various scaffolds in the absence or presence of additional 
growth factors to form the synthetic engineered tissue or organ.[3]  The engineered 
product is then re-implanted into the body as a substitute for the failed tissue or organ.   
 
Figure 2.1  Conventional cycle in tissue engineering. Cells are harvested from donor and 
expanded in vitro to generate more cells. These cells can then be combined with scaffolds and 
growth factors to form engineered tissues for implantation. 
Several factors are crucial in determining the success of a tissue engineering 
approach.  These include the availability and viability of donor cells, the bioavailability 
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and the activity of the delivered growth factors, and the ability of the scaffold to support 
function and integration with local tissue.[1-3]  A great deal of research has been 
undertaken in each of these areas.  In this literature review, cell-instructive tissue 
engineering scaffolds will be covered in the earlier sections, and the delivery of cytokines 
to further augment tissue regeneration will be covered in the later sections.   
2.2 Cell-instructive tissue engineering scaffolds 
Traditionally, tissue engineering scaffolds have been designed with the sole 
purpose of providing structure and support for cell delivery.  It has since become 
apparent that engineered scaffolds can be designed to carry out many other functions in 
the body.[1, 3, 4]  With the right topographical cues, scaffolds can be used to direct cell 
organization.[3, 5]  Not only that, the local availability of bioactive molecules and 
cytokines can be regulated through encapsulation or tethering.[1]  Recent studies have 
also demonstrated the crucial role of scaffold mechanics in regulating cell signaling and 
cell cycle.[6]  Apart from use in tissue engineering and regeneration applications, these 
scaffolds are also increasingly used for both cell culture and fundamental science 
research, in attempts to recapitulate native responses ex vivo.[7]  In addition, these 
scaffolds also serve to bridge the gap between simple two dimensional (2D) tissue culture 
plates and complicated animal studies as their geometric complexities and intricacies 
provide a more realistic approximation to native structures.[7]   
Due to the polymeric nature of the extracellular matrix (ECM), a wide variety of 
synthetic and naturally-derived polymeric materials have been utilized in scaffold 
fabrication.  These polymers are processed by a wide variety of methods such to form 
different types of scaffolds such as foams, meshes, beads and hydrogels to name a few.[1, 
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8-11]  In general, stiffer scaffold materials have been used for regeneration of harder 
tissues such as bone and cartilage.[8, 10]  These scaffolds are usually made from 
hydrolytically degradable materials such as poly(lactide-co-glycolide) (PLGA) and are 
typically processed under harsh conditions in the organic solvents before subsequent cell 
seeding.[11]  For the repair of softer tissues and organs, hydrogels are preferred due to 
their structural similarity to native ECM and their mild processing conditions.[1, 4, 7] 
2.3 Hydrogel scaffolds 
Hydrogels, which comprise of cross-linked hydrophilic polymeric networks, are 
said to have much structural similarity to native ECM components.  Thus, they provide a 
better mimic of key ECM attributes such as growth factor transport and retention.[1, 4, 7]  
Furthermore, these materials generally facilitate transport of oxygen, nutrients and waste 
products, and are easily customizable to present different bioactive motifs and adhesion 
sites.[1, 4, 7]  The reactions to form hydrogels are also usually mild and cell-
compatible.[9]  This allows easy encapsulation of cells within hydrogel scaffolds to 
provide three-dimensional (3D) stimulation.  In addition, most hydrogels or their pre-gel 
solutions are injectable for minimally invasive surgical techniques.[9]  They can also be 
used fill tissue defects.  Finally, the mechanical properties of certain hydrogels also 
mirror that of softer tissues in the body, thus allowing mechanotransduction in vivo to be 
reproduced.[7]  
Hydrogels can be broadly classified into two categories – promoting and 
permissive hydrogels.[1, 7]  Promoting hydrogels are capable of promoting cell function, 
viability and proliferation without the need for additional processing.[1, 7]  These 
hydrogels are usually derived from biological sources and thus contain endogenous cues 
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such as growth factors and cell-adhesion sites.  Promoting hydrogels include native ECM 
components such as laminin, fibrin, collagen, Matrigel, and hyaluronic acid.  [1, 7]  
Although these materials promote good cell function, their inherent complexity may 
render them unsuitable for fundamental scientific studies.  Furthermore, as these hydrogel 
materials are often obtained from animal sources, there exist batch-to-batch variability 
and concerns of xenozoonosis.  In addition, it might be difficult to customize the inherent 
properties of these natural materials to cater to specific applications.[1, 7]   
Permissive hydrogels, on the other hand, maintain the viability of encapsulated 
cells but might result in compromised cell proliferation, function and spreading.  Such 
gels are usually generated from synthetic polymers such as poly(ethylene glycol) (PEG) 
and poly(vinyl alcohol) (PVA).[1, 7]  Although these materials do not inherently promote 
cell function, they can be customizable to present appropriate ligands for cell adhesion 
and cell-signaling.[7, 12]  There is also no concern for xenogeneic contamination with 
these permissive hydrogels.   Furthermore, synthetic permissive hydrogels are highly 
reproducible and customizable as compared to the naturally-derived hydrogels.  However, 
many features might have to be incorporated into the permissive gels before they can 
possess levels of promoting functions that are similar to the naturally-derived hydrogels.   
2.4 Hydrogel scaffold design considerations 
 To generate hydrogels scaffolds for 3D cell cultures, the hydrogels should ideally 
be both promoting of cellular activities and customizable to meet specific requirements of 
the study.  To bridge the gap between natural and synthetic hydrogel materials, two 
different approaches have been adopted.  The first approach involves modification of 
synthetic hydrogels through the addition of various cell-promoting factors such as cell-
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adhesive peptide sequences and ECM components e.g. collagen and laminin.  In the past 
few years, a large array of cues has been incorporated into PEG-based hydrogels to 
generate a milieu of specialized hydrogels, thus demonstrating the versatility of this 
approach.[12]  While this method of adding specific cues on demand produces highly 
customizable hydrogels scaffolds, opponents of the approach argue that these matrices 
may still not fully recapitulate the cell-promoting functions of naturally-derived 
hydrogels due to the inherent complexities in the latter.[13]  Furthermore, as a number of 
naturally-derived gels such as collagen and hyaluronic acid have already been approved 
by the United States Food and Drug Administration (FDA) for medical use, the efforts to 
reproduce these materials with synthetic hydrogels are criticized by some as re-inventing 
the wheel.[14-16]   
The second approach involves the modification of natural hydrogel materials 
through various means to impart specific structural and mechanical characteristics.[17]  
This method may require less effort as fewer attributes have to be imparted to these 
inherently promoting materials.  However, due to the complexities of the natural 
hydrogels, it can be difficult to predict the final material properties, thus requiring 
numerous iterations of trial and error before the desired product can be obtained.  
Furthermore, unwanted changes to material properties such as loss of bioactive moieties 
might result from the modification of the natural hydrogels. 
 Regardless of the approach, there are several key requirements that should be 
present in all good 3D cell culture hydrogels for both tissue regeneration and ex vivo 
applications.  These attributes are (i) well-defined stiffness that is controllable within the 
physiological range, (ii) presence of cell-adhesion moieties to promote good cell adhesion, 
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(iii) good permeability to oxygen and nutrients, and (iv) non-toxicity to maintain cell 
viabilities.[7]  Depending on the final intended application, other attributes might also be 
important.  For example, if the hydrogel is intended to allow active remodeling by cells, 
the material should be cleavable by endogenous matrix metalloproteinase (MMP) 
produced by the cells; or if the hydrogel is required to gel in situ at a defect site, it should 
gel under mild conditions within suitable time frames.[1, 7]   
Unfortunately, a great obstacle in the design and customization of hydrogel 
scaffolds lie in the interdependency of the various hydrogel properties.  For instance, it 
may be common to use a variety of cross-linking reactions to alter the mechanical 
properties of hydrogels.  However, such reactions may be accompanied by the undesired 
reduction in hydrogel permeability which might then result in reduced cell viability (Fig. 
2.2).  The alternative approach of changing total polymer concentration is likewise 
accompanied by similar reduction in hydrogel permeability.[18]  In addition, the varying 
of total polymer concentration might also alter the concentration of bioactive components 
such as cell-adhesion sites in the hydrogel, thus leading to an unintended change in cell 
signaling.[9, 19, 20] 
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Figure 2.2 Interdependency of hydrogels stiffness and permeability.  In conventional 
hydrogels, increasing stiffness by either (a) increasing cross-linking density or (b) increasing total 
polymer concentration result in the simultaneous reduction in permeability. 
 These obstacles have greatly limited research in this area.  Owing to the 
conflicting requirements in 3D hydrogel design, many experiments involving hydrogels 
have been confined to the 2D configuration where issues concerning material 
permeability and cell viability are greatly simplified.  However, it is now well-established 
that there might be limited connection between observations in the 2D and 3D 
configurations.[7]  Cell culture on 2D substrates has now been shown to produce vast 
differences in cell morphology, phenotype and gene expression (Fig. 2.3).  In 2D culture, 
cells’ interactions with the scaffold are polarized and are limited to a single plane.[7]  The 
cells are also not exposed to any local gradients of soluble factors that are usually present 
3D within matrices.  Moreover, the migration of cells and interaction between 
neighboring cells on a 2D substrate is also altered.[7]  As such, the 2D format provides a 
poor approximation to physiological conditions, and observations made in this 
configuration should not be generalized to cells in vivo and in 3D hydrogels.  
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Figure 2.3 Culture of liver cancer cells in 2D and 3D.  (a) When the liver cancer cells are 
cultured in 2D, they spread and proliferate extensively to form cell layers.  (b) When the liver 
cancer cells are cultured in 3D matrices with liver-like stiffness, the cells are well-organized into 
spheroids with suppressed proliferation. (Scale bars represent 50 µm)    
 Albeit there are still many new studies adopting the 2D culture format, increasing 
efforts have gone into surmounting the challenges in 3D hydrogel design.  For instance, 
the dependency between hydrogel stiffness and permeability had recently been decoupled 
by introducing pendant chains into PEG-based polymer network.[19]  By varying the 
ratio of the pendant PEG chains to bi-functional PEG, our group was able to vary the 
modulus of the hydrogel while minimally changing its permeability.  In another work to 
decouple polymer stiffness and hydrogel swelling ratios, it was found that the 
incorporation of methacrylic alginate into a poly(ethylene glycol) dicarylate (PEGDA) 
hydrogel allowed the stiffness to be modulated while minimizing changes to the 
hydrogels’ swelling ratios.[20]  These innovative ways of decoupling interdependent 
parameters contribute significantly to the tool sets for customizing 3D hydrogels. 
 When designing hydrogels matrices for 3D culture, it is essential to keep in mind 
the key requirements for 3D cell culture scaffolds, specific considerations for the study at 
hand, and the cells’ native microenvironment.  For basic science studies investigating the 
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cell-ECM interactions, it may be crucial to have good control over specific parameters of 
interests while minimally affecting other parameters.  However, for tissue regeneration 
applications, it is advantageous to mimic the native ECM and promote cell-mediated 
matrix remodeling.  All-in-all, it is paramount for tissue engineers to be equipped with a 
sound understanding of the native ECM before embarking on hydrogel scaffold design 
and fabrication. 
2.5 Native ECM 
 Before designing 3D hydrogel scaffolds, it is essential to have a sound 
understanding of the native ECM in terms of its unique structure and function.  The ECM 
comprises an intricate network of proteins such as collagen, fibronectin and laminin, and 
polysaccharides such as glycosaminoglycan (GAG) (Fig. 2.4).[21, 22]   The major 
component of the ECM is triple-helical collagen fibrils.  Depending on the tissue location, 
collagen within the ECM is further processed to impart requisite properties.  For instance, 
collagen within tendons assemble into rope-like structures which provides tremendous 
strength, and collagen fibrils in skin and tendon undergo increased cross-linking to 
provide greater tensile strength.[21, 23, 24]  Another key component in ECM is 
fibronectin.  Fibronectin is a multi-domain glycoprotein.  The domains include the 
heparin-binding domain, the collagen-binding domain, and the well-known peptide 
sequence Arginine-Glycine-Aspartic Acid or RGD that is responsible for cell-binding.  
Fibronectin is not only important for cell-adhesion, the location and distribution of 
fibronectin can also guide cell migration.[21, 25]  The ECM is also composed of the 
basal lamina which is formed primarily by laminin.  One essential function of the basal 
lamina is to act as a selective barrier to cells.  For instance, the basal lamina beneath the 
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epithelium permits the movement of macrophages, lymphocytes and nerve processes 
through it but blocks the transport of fibroblasts.  The basal lamina also plays key roles in 
regulating the function of synapses and neuromuscular junctions.[21]  Other than the 
protein constituents, the ECM also contains hydrophilic GAG chains.  These chains 
regulate the turgor pressure of the ECM through their specific swelling.[21, 26]  They 
also regulate the presentation of bioactive molecules to cells through local sequestration 
and sieving action.   
 
Figure 2.4 The ECM is an intricate network of proteins and polysaccharides. The proteins in 
the ECM include collagen, fibronectin and laminin.  The cells interact with the ECM through integrin 
receptors. [22]   
 The ECM is a dynamic structure that is in constant communication with the cells.  
It is remodeled by adjacent cells through cell-exerted forces, and is also continually 
renewed through well-regulated processes of matrix degradation and synthesis.[21, 23]  
At the same time, the ECM provides a myriad of cues to direct organization of cellular 
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cytoskeleton, cell signaling, and function.  Through the study and understanding of cell-
ECM interactions, the design of cell-instructive hydrogel scaffolds can be further 
improved and optimized. 
2.6 Cell-ECM interactions 
 The cell surface possesses two classes of receptors for interaction with the ECM.  
These receptors are the non-integrin and integrin receptors.  The non-integrin receptors 
include a number of laminin-binding proteins and proteoglycans such as CD 44 and 
syndecan.  CD 44 is able to bind to a variety of ECM components including type I 
collagen, type IV collagen, and GAG; while syndecan is able to bind with collagen, 
fibronectin and growth factors such as basic fibroblast growth factor (bFGF).[27]  
Expression changes of certain non-integrin receptors have been associated with changes 
in cell adhesion, migration, morphology, and cell differentiation.  The integrin receptors 
are a subset of the glycoprotein receptors.[27]  These receptors are made up of the non-
covalent association of α and β subunits.  In mammals, eighteen α subunits and eight β 
subunits have been characterized.  This allows a wide variety of integrin receptors to be 
formed from different combinations of α and β subunits.  α subunits recognize different 
short sequences present in the ECM and are responsible for ligand specificity.  β subunits, 
on the other hand, are said to have limited ligand specificity and are more essential for 
cytoskeletal association and specific intracellular changes. [27, 28]  
 As cells bind to ECM components through different integrin or non-integrin 
receptors, changes in their intracellular domains occur.  This in turn mediates 
transformations in the cytoskeleton near the adhesion sites.  Subsequently, other 
intracellular proteins may be roped in to form focal adhesion complexes (FAs).[29]  The 
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formation of such FAs can then further promote longer range cytoskeleton rearrangement 
to alter cell shape or chromatin configuration.  As a result of cell-binding to specific 
ECM components, different cascades resulting in altered gene expression, proliferation or 
differentiation may be triggered.[29]   
Many studies have focused on relating changes in ECM properties to different 
cellular responses.  The ECM cues that are most commonly investigated in these studies 
are surface chemistry, topographical features, and mechanical properties.[6, 30-32]  
These cues can also be applied in combination within complex 3D environments.  Such 
investigations of different cell-instructive ECM cues may shed light on the complex 
changes in ECM and cells during both physiological processes (such as cell 
differentiation and wound healing) and pathological changes (such as malignant 
transformations).  The studies will also facilitate the design of specialized hydrogel 
matrices for directing specific cell responses such as cell proliferation or differentiation.   
2.7 Scaffold-directed cell responses 
 As mentioned, the roles of different scaffold cues (such as surface chemistry, 
topography, and mechanical property) on cell behaviors have been the subject of much 
investigation.[6, 30-32]  Due to the inherent complexities on the native ECM, many of 
these studies were conducted using customized synthetic scaffolds.  The study of surface 
chemistry-cell relationships has been made possible by many enabling technologies and 
has led to substantial useful outcomes.  The invention of new conjugation strategies has 
made the grafting of different moieties on various substrates possible; and the inclusion 
of flexible tethers has allowed cells to remodel covalently conjugated signaling 
molecules.[30]  The screening of different surface-conjugated molecules has led to the 
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discovery of many active molecules capable of supporting cell growth and cell spreading.  
These molecules include peptide sequences, such as the well-known RGD sequence, and 
carbohydrates such as galactose.[30]  Such moieties are now incorporated into many cell 
culture scaffolds to impart cell-adhesive functions.  Another example of a key discovery 
in this area is the applicability of thermo-responsive poly(N-isopropylacrylamide) 
(PNIPAM) in cell culture.[33]   By changing the ambient temperature, this polymer 
allows the attachment and detachment of cells through the changes in the polymer’s 
wettability.  This polymer system is now widely used in the generation of cell sheets for 
tissue regeneration.[33]   
 With respect to topographical cues, nano- and micro-scale topographical features 
such as grooves and pillars have been patterned onto different substrate surfaces.[31, 32]  
These topographical features may also be accompanied by further chemical modifications.  
In general, the features may be broadly classified into two categories, namely, anisotropic 
and isotropic patterns.[31, 32]  Anisotropic patterns such as grooves tend to result in 
pronounced changes in cell shape.  These changes in cell shape may in turn induce 
polarized cytoskeletal tensions and may lead to subsequent changes in nuclear shapes and 
cell migration tendencies.[31, 32]  It has been shown in different studies that the up-
regulation of cytoskeletal tension on these anisotropic substrates enhanced the 
differentiation potential of mesenchymal stem cells (MSC)s into elongated cell lineages 
such as neurons and osteoblasts.[34, 35]  When cells are cultured on isotropic patterns, 
they tend to undergo less obvious changes in shape.  However, these cells might still 
show pronounced differences in several cell functions such as adhesion, proliferation and 
differentiation.[34, 36]  It was found that when neural stem cells were cultured on 
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isotropic fiber meshes with decreasing fiber diameters from 1452 nm to 283 nm, there 
was a corresponding increase in proliferation and decrease in aggregation.[37]  The 
culture on the fibers of different diameters also resulted in different differentiation 
characteristics.  When cultured on the smallest fibers, the cells had a higher propensity to 
differentiate into oligodendrocytes.[37]  However, when grown on fiber with 
intermediate thickness, the cells had higher propensity to differentiate into neurons.      
Of the different scaffold cues, the effect of scaffold mechanical property has 
generated the most interest among cell biologists.  While the chemical and topographical 
cues under investigation are usually synthetic in nature, mechanical property of the native 
ECM has been observed to vary according to tissue location, physiological states and 
pathological states.  In the body, the stiffness of the ECM may vary up to several orders 
of magnitude from the brain to mineralized bone.[6, 38]  As there are many methods to 
quantify and control the mechanical properties of both natural ECM and synthetic 
scaffolds, matrix rigidity can serve as a useful design parameter for the design of cell-
instructive hydrogels.[23]  To better utilize matrix rigidity as a scaffold cue in cell-
instruction, the reciprocity between matrix mechanics and cellular activities should be 
thoroughly studied.     
2.8 Effect of matrix stiffness 
Cells probe and sense the elasticity of their substrates through different means.  In 
load-bearing tissues such as bones, cells undergo mechanical stress and strain from the 
ECM, in the form of outside-in simulation.[6, 39]  At the same time, cells in other softer 
tissues may also detect ECM mechanics through inside-out simulation, by pulling on 
their substrates.[6, 39]  In this mode, forces generated by cells’ myosin are transmitted 
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through FAs to tug on the surrounding matrix.  These FAs are integrin clusters that 
physically link the cells’ actin cytoskeleton to the ECM.  According to the different 
resistances sensed by the cells, their cytoskeleton is further reorganized to regulate cell 
shape.[40]  Concurrently, the activation state of FA kinases might be altered to regulate 
downstream cellular processes such as proliferation and differentiation.[41]  Recent data 
has shown that while cells experiencing tensional stresses exhibited increased 
proliferation, compression tended to suppress proliferation and slow growths.[42-44]  
Such mechanical feedback helps in maintaining regular tissue shape and tissue 
homeostasis.  The role of stiffness in regulating differentiation has also been highlighted 
in numerous studies.  In embryogenesis, key changes leading from convergence and 
extension movements during the gastrulation of Xenopus laevis were shown to only occur 
when the mesoderm and notochord cell layers were stiff enough to withstand 
buckling.[45]  In a separate study, it was also found that gene expression during early 
embryonic development was significantly altered by substrate stiffness.  On stiffer 
substrates, several genes implicated in early mesoderm differentiation such as Foxa2 and 
Brachyury were up-regulated as substrate stiffness increased from 41kPa to 2.7 MPa.[46] 
There was also a subsequent up-regulation of osteogenic differentiation of the mesoderm 
on the stiffer 2D substrates.   
Other than regulating key cellular processes, aberrant mechanical stimuli are also 
associated with abnormal signaling in different diseases such as cancer and fibrosis.  This 
area has evoked great interest as greater understanding of the reciprocal relationship 
between tissue stiffness and disease state might yield novel preventive measures and 
alternative therapeutic approaches.[44, 47] 
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2.9 Effect of matrix stiffness on cancer cells 
In recent years, there is increasing evidence that tumor malignancy is not only 
directed by genetic mutations in the cells but also by the cells’ microenvironment.  
Tumors are usually characterized by their increased local stiffness which renders them 
palpable or detectable through transient elastography.[48]  The stiffer tumor tissue is 
often accompanied by increased collagen cross-linking and collagen deposition.[49, 50]  
Cancer cells are also shown to possess increased sensitivity to substrate stiffness as 
compared to their non-malignant counterparts.[51]  This increased sensitivity is mediated 
by increased activation of Rho-dependent actin-myosin contraction and enhanced actin 
assembly.[44]  In addition to its role in regulating cellular tension, Rho activation has 
been linked to increased cell proliferation in many cancers.  Conversely, the inhibition of 
the Rho-dependent actin-myosin contraction through genetic manipulation or 
pharmacological action significantly reduced cellular tension and resulted in less 
malignant phenotypes.[51]   
To investigate the effects of substrate stiffness on cancer malignancy, a milieu of in 
vitro and in vivo experiments had been carried out both in the 2D and 3D format.  In the 
2D configuration, it was observed that for certain cancer cells, such as breast and lung 
cancer cells, increased matrix stiffness tended to result in increased proliferation and 
more malignant phenotypes.[52, 53]  This could be attributed to the integrin clustering in 
the 2D configuration which resulted in the formation of FAs, subsequently leading to the 
downstream activation of Rho.  However, in the 3D configuration, mixed effects have 
been observed. While several studies reported similar increase in malignancy with 
increasing stiffness, other studies observed reduction in cell proliferation and increase in 
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apoptosis when matrix stiffness was increased.[51, 54]  The diverse effects could be 
attributed to the difference in ranges of mechanical properties being investigated.  
Alternatively, due to the diversity of the 3D matrices under investigation, these matrices 
could also provide vastly different mechanical cues to the entrapped cells as a result of 
the inherent differences in matrix structure and organization.[51, 54]  The findings from 
these studies in the 3D configuration seemed to suggest that while increased tensional 
strains led to increased proliferation and cell migration, high compressive strains tended 
to result in suppressed proliferation and increased apoptosis.  Such regulation is not 
unlike the tissue homeostasis observed in oogenesis.[42, 43]   
These studies, coupled with the observation that tumor tissues generally possess 
increased stiffness, have led to the conjecture that tumors in the body could have arose 
from abnormal increase in the ECM stiffness.[55]  However, emerging research has also 
demonstrated that conditional activation of Rho-associated protein kinase (ROCK) in 
cancer cells subsequently led to increased collagen deposition and increased stiffness of 
the surrounding ECM.[55]  Hence, although tumors are often observed with increased 
ECM stiffness, it is still debated if the increased ECM stiffness caused tumors or vice 
versa.  However, from the numerous in in vitro and in vivo experiments, it appeared that 
any departure from normal matrix stiffness likely increased the propensity for malignant 
transformations through aberrant cell-signaling.     
2.10 Effect of matrix stiffness on fibroblasts 
Apart from cancer, profound changes to local tissue stiffness have also been 
observed in tissue fibrosis or pathological cirrhosis.[56] Such observations are related to 
the activation of resident fibroblasts.  When subjected to different stimuli, the fibroblasts 
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undergo various phenotypic and morphological transformations.  These activated 
fibroblasts termed protomyofibroblasts, developed stress fibers, showed up-regulated 
expression of actin, and developed stronger cell-cell interactions.[57, 58]  Through these 
concerted changes, the protomyofibroblasts formed bundles that had much higher 
contractile function than the non-activated counterparts.  Further activation subsequently 
resulted in the transformation into myofibroblasts, characterized by the expression of α-
smooth muscle actin (α-SMA) and the exhibition of even greater contractile activities. 
[57, 58]   
  Both in vitro and in vivo experiments have demonstrated the strong link between 
local mechanical stiffness and the activation of residing fibroblasts.[47, 56]  During tissue 
injuries, the local disruption of the ECM can also lead to the indirect up-regulation of 
cellular tension, which in turn brings about fibroblasts activation.  Alternatively, the 
fibroblasts may be activated by cytokines which are locally released from inflammatory 
cells during tissue injury.  One major activator of fibroblasts in pulmonary fibrosis is 
transforming growth factor- (TGF-).[59]  The activated protomyofibroblasts and 
myofibroblasts subsequently remodel the ECM through increased matrix synthesis, 
deposition, and increased contraction.[58, 60]  Such fibroblast-mediated remodeling 
serves to speed up wound healing by closing up gaps in the ECM.  Under normal 
conditions, the reconstructed ECM takes over the mechanical load and shields the 
protomyofibroblasts or myofibroblasts from additional stress.[61]  This stress release 
subsequently promotes apoptosis of the myofibroblasts to prevent excessive contraction 
and abnormal stiffening of the local tissues, thus restoring normal tissue function.[61]   
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Several factors, however, could result in the failure of the myofibroblasts to 
undergo timely apoptosis.  These include persistent up-regulation of inflammatory 
cytokines due to repeated injuries or over-stiffening of the local ECM.[62]  These factors 
have been identified as the culprit for abnormal fibrosis or cirrhosis, resulting in tissue 
damage and ultimately tissue failure.  Recent studies have shown the reduction of 
intracellular tension to be promising for managing the activation state and subsequent 
activities of fibroblasts.  This can be achieved by increasing ECM compliance or by 
blocking cell-ECM interactions.[63]  However, many of these studies were conducted in 
the 2D dimension.  To further refine these strategies, the development of better in vivo 
and 3D in vitro models will provide a better understanding of pathologic fibrosis.  In 
addition, it is also necessary to generate more refined methods to accurately quantify the 
stiffness of tissues and fabricated scaffolds at different length-scales.   
2.11 Quantification of matrix stiffness 
While there is increasing awareness of how scaffold and ECM stiffness may affect 
cell phenotypes in physiological and pathological processes, the different studies employ 
diverse strategies to quantify the matrix stiffness and differ on the stiffness values 
reported.  The local stiffness of the ECM or scaffold is usually quantified by the bulk 
elastic modulus of the material.[6]  The elastic modulus quantifies a material’s intrinsic 
resistance to stress and is defined as the slope of a stress-strain curve in the elastic 
deformation regime.  A stiffer material will have a higher elastic modulus while a softer 
material will have a lower elastic modulus.   
A variety of macro-scale and micro-scale techniques have been developed to 
quantify the mechanical properties of scaffolds and soft tissues.[6, 64]  The most 
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commonly used methods include macro-scale methods implemented by applying a 
compressive or tensile force and then measuring the relative change in length or strain.  
Such approaches are commonly used due to ease of measurement and the availability of 
the machines.[6, 64]    However, these methods only capture the macroscopic or bulk 
material stiffness and tend to overlook the microscopic features and subtleties in the 
native ECM and in synthesized scaffolds.[6, 64]   In particular, the length and time scales 
that are relevant to cell-sensing are often not captured in macro-scale measurements.  To 
obtain mechanical properties in a more physiologically relevant length-scale, alternative 
methods such as measurement with atomic force microscopy, micro-, and nano-indenters 
have also been used.[64]  However, these methods may also be accompanied by other 
disadvantages such as specialized equipment and high cost.  Due to the innate softness of 
biological samples, the capillary forces experienced by the tips or indenters might also 
exceed the forces associated with the indentation of the sample.[64]  Furthermore, due to 
the sensitivity and compliance of biological samples, the measurement errors are also 
compounded by variations in sample preparation methods.  For example, the reported 
elastic moduli of brain tissue might vary by a factor of 2 or more depending on the 
method of preparation.[65]  An alternative method of determining local or micro-scale 
mechanical properties would be to obtain these properties through available models or 
equations.  For example, with the storage modulus and mesh size of a polymer network, it 
is possible to calculate the rigidity of the individual fibers from the MacKintosh 
model.[66]  Nevertheless, such methods are usually subjected to various assumptions and 
thus are only good for providing estimates. 
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 Although it remains a challenge to obtain accurate and consistent mechanical 
measurements of soft tissues and biological samples, the key message is that there are 
inherent differences between the mechanical properties of different tissues such as bone, 
brain, muscles, fat, and liver.[38]  These differences could attribute to phenotypic 
differences of the different cell types.[67]  Due to the possible variations generated by 
different methods of sample preparation and measurements, it is ideal to use a standard 
method of sample preparation and measurement when comparing different conditions.  In 
addition, when interpreting stiffness values published in the literature, one should 
remember that different methods of measurements often yield different values.  
Furthermore, it is important to keep in mind that the macro-scale methods of measuring 
mechanical properties tend not to account for micro-scale features in the cell-sensing 
length-scales, such as stiffness gradients and differences in local rigidities.  Having 
discussed how tissue and scaffold stiffness might be quantified, the various methods for 
controlling scaffold mechanical properties will next be discussed.     
2.12 Scaffold modification to control stiffness 
With increasing understanding of how mechanical properties regulate cellular 
processes, many studies have started investigating cell-instructive scaffolds with tunable 
mechanical properties.  A wide variety of techniques has been devised to both increase 
and decrease elastic moduli of hydrogel scaffolds.  One common method for increasing 
elastic modulus involves increasing the concentration of the bulk constituting 
polymer.[19, 20]  For example the elastic moduli of agarose or collagen gels are typically 
controlled by varying agarose and collagen concentrations respectively.  With this 
method, it is easy to generate a spectrum of mechanical properties.  However, one major 
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concern is the significant decrease in material permeability with increasing polymer 
concentration.[19, 20]  While this does not pose a major concern when cells are cultured 
in the 2D format, decrease in material permeability in 3D scaffolds may restrict the 
transport of nutrients and oxygen to cells.  Furthermore, when natural polymers such as 
collagen are used, changing the concentration of collagen also means simultaneous 
changes in bioactive motifs such as cell-binding sites.  These changes might alter cell 
activity and complicate scientific studies.[68]     
An alternative method for controlling hydrogel stiffness would be to regulate the 
cross-linking density of the hydrogel network whilst maintaining constant total polymer 
concentration.  This can be implemented in various ways.  For example, a greater number 
of reactive functional groups can be grafted onto the polymer backbone chain to allow a 
greater degree of cross-linking.[69]  By varying the degree of substitution on a polymer 
backbone chain, a spectrum of cross-linking densities and elastic moduli can be generated.  
In the case of photo-polymerizable hydrogels, the degree of cross-linking can also be 
regulated by varying the initiator concentration and the irradiation duration and 
intensity.[70]  This method is easily implemented without the need for prior chemical 
modification.  Alternatively, the cross-linking density of a hydrogel network can also be 
controlled by regulating the cross-linker concentrations.  A large variety of cross-linkers 
are now available for reaction with different end groups.  These include homo-
bifunctional cross-linkers, hetero-bifunctional cross-linkers, and multi-arm cross-linkers.  
Cross-linkers of different lengths have also been used to generate zero-length cross-links, 
short bridges, or long bridges.[71, 72]  Apart from chemical cross-linkers, enzymes e.g. 
lysyl oxidase and transglutaminase, and biochemicals e.g. ribose have also been used to 
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cross-link natural polymers such as collagen.[73-75]  Whilst the cross-linking approach 
allows stiffness to be tuned without changing the concentration of the main constituting 
polymer, other concerns such as possible cytotoxicity of initiator, cross-linker or 
irradiation should also be considered.  Prior to implementation, there needs to be 
thorough investigation to ensure that the chosen method of cross-linking does not 
significantly affect the viability of the cells.  This is especially important for 3D in situ 
cell encapsulation.  Furthermore, the permeability of the hydrogel scaffolds might still be 
significantly decreased if the cross-linking density is too high.[9, 19, 20]  Hence, this is 
another key parameter that should be examined.  The permeability of hydrogels usually 
depends on the polymer concentration, cross-linking density, length of polymer precursor, 
and nature of polymer.[76]  It should be noted that hydrogels made from shorter synthetic 
polymers such as PEG (MW < 5000 Da) tend to have smaller mesh sizes and lower 
permeability while hydrogels from natural polymers such as collagen tend to have larger 
mesh sizes and higher permeability.[76]  While cross-linking with enzymatic and 
biochemical cross-linkers are associated with lower cytoxicity, it should also be noted 
that these methods often generate a smaller range of stiffness and may yield less 
consistent results. 
In addition to the cross-linking of polymeric hydrogels to increase the overall 
elastic moduli, the local moduli of fibrous hydrogels can also be tuned by controlling the 
local diameters and rigidities of constituting fibers.[77]  One common way of varying the 
fiber diameter of hydrogel is to use electrospinning.  In this method, various parameters 
such as the flow rate and charge can be varied to control the final fiber sizes.[78]  
However, with this method, it might be challenging to encourage cell migration into the 
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electrospun scaffolds for subsequent cell culture.[79, 80]  Alternatively, electrospinning 
can also be used for the direct encapsulation of cells within the fibers through the 
incorporation of cells into the pre-polymer solution.[81]  Another approach for varying 
the diameters of self-assembling fibrous hydrogels is to change self-assembly conditions 
such as temperature and pH.[32]  While these methods have been used to successfully 
vary the fiber diameters of self-assembling fibrous gels such as collagen gels, there has 
been limited application to in situ cell encapsulation as the varying temperature and pH 
might significantly alter cell viability and activities.  As such, new methods to control 
fiber diameters of fibrous gels have to be examined. 
Other than these common methods to increase scaffold rigidity, several approaches 
for softening scaffolds have also been proposed.  The gradual degradation or softening of 
pre-formed scaffolds is often important in in vivo applications so as to allow the 
regenerating host tissues to gradually take over and perform their functions.[82]  This 
gradual softening or degradation can be achieved by employing degradable natural 
polymers or by adding cleavable sequences such as MMP-cleavable peptide sequences to 
synthetic hydrogels.[82]  In more recent years, the softening of hydrogels on demand has 
also been explored.  Cell-encapsulating hydrogels that can be softened on demand can 
serve as useful models allowing the study of dynamic responses such as proliferation and 
cell migration in response to introduced changes in tissue stiffness.  The softening of pre-
formed scaffolds on demand can be easily achieved through the enzymatic degradation of 
degradable hydrogels or by using readily cleavable bonds such as disulfide bridges.[83]  
In addition, pH-sensitive polymers have been incorporated into hydrogels to allow tuning 
of mechanical properties with changes in pH.[84]  More recently, photodegradable 
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groups were also incorporated into PEG hydrogels to allow for both spatial and temporal 
regulation of hydrogel stiffness by using controlled laser pulses.[85]  Although there are 
various approaches to soften pre-formed hydrogels, it is essential to ensure that the 
approaches used for softening, be it enzymatic degradation, reduction of disulfide bridges, 
or photo-degradation, do not affect cell viability or activity.                       
As discussed, there are many different approaches to control both the overall and 
local stiffness of hydrogel scaffolds.  Each of these methods presents their unique 
advantages and disadvantages.  However, when choosing appropriate modification 
methods and hydrogel platforms, it is essential to also consider to ultimate application of 
the hydrogel scaffold.  In this study, the hydrogel scaffolds will be designed for use ex 
vivo as models for studying cell-scaffold relationships, and also in vivo as cell-support 
system.  To meet the varied requirements, we will be using collagen-based hydrogel 
scaffolds.  The main features and advantages of collagen-based hydrogels will next be 
discussed.           
2.13 Collagen-based hydrogel scaffolds 
Collagen is widely used for many biomedical applications as it is the most 
abundant protein in mammalian tissues and also the main component of natural ECM.[86]  
Bovine collagen has also been approved by the FDA for various invasive and non-
invasive medical applications.[16]  Acid-solubilized collagen strands can self-aggregate 
to form stable fibrils and fibers.[87]  These fibers can further entangle to form collagen 
hydrogels.  Due to their bio-active and cell-adhesion sequences, collagen hydrogels are 
natural promoters of cell-activities.  Furthermore, the mechanical properties of collagen 
hydrogels can be increased by introducing various chemical cross-linkers (e.g. bi-
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functional cross-linkers and glutaldehyde), biomolecules (e.g. ribose), by crosslinking 
with physical treatments (e.g. UV irradiation, freeze-drying, heating), or by cross-linking 
with enzymes (e.g. lysyl oxidase).[88-91]  The stiffness or collagen hydrogels can also be 
decreased through enzymatic degradation by MMPs or collagenase.[21]  Furthermore, the 
fibrous structure of collagen hydrogels can also be tuned by altering the self-assembly 
conditions such as temperature and pH.[77]  Due to the customizability and cell-
promoting activities of collagen, collagen-based hydrogels will be modified by different 
strategies to generate various microenvironmental cues in cell-instructive scaffolds.   
Following the earlier discussions of cell-instructive scaffolds, the second 
component of tissue engineering i.e. soluble cues will be discussed in the coming section.    
2.14 Controlled delivery vehicles used in tissue engineering 
As mentioned in the earlier sections of this chapter, the success of tissue 
engineering and regeneration strategies is dependent on three different factors i.e. the 
cells, the scaffold and the soluble factors. [1-3]  While the focus in the earlier sections 
was primarily on the scaffolds, we now switch gears to the provision of soluble factors to 
regulate tissue regeneration.  Tissue regeneration usually takes place in many steps.  For 
example, the cascade of events required for endogenous liver regeneration is regulated by 
a myriad of soluble factors including hepatocyte growth factor, epidermal growth factor, 
urokinase-type-plasminogen-activator, TGF-1, epiregulin, tumor necrosis factor-, 
norepinephrine, -2-macroglobulin.[92]  These factors are tightly regulated in terms of 
their spatial and temporal presentation to ensure that each of the steps in the regeneration 
cascade is performed correctly.   
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The different classes of soluble proteins and peptides that are used for tissue 
regeneration and tissue engineering applications include growth factors, anti-
inflammatory factors, anti-apoptotic factors, chemokines, colony stimulating factors and 
MMPs.[93-98]  Growth factors such as vascular endothelial growth factor (VEGF), 
platelet-derived growth factor (PDGF) and bone morphogenic protein (BMP) have been 
used to stimulate the local vascularization, growth, proliferation and differentiation of 
target tissues.[93, 98]  Both anti-inflammatory factors and anti-apoptosis factors such as 
IL-10 and BH-4 anti-apoptotic peptides have been extensively employed to promote the 
survival of regenerating tissues at sites of injuries.[94, 95]  Chemokines, also known as 
chemotactic cytokines, play an important role of recruiting endogenous stem and 
progenitor cells to carry out repair of the damaged tissues.[96]  The recruited stem and 
progenitor cells may also secrete various cytokines to promote tissue repair.  Colony-
stimulating factors such as the granulocyte colony stimulating factor (GCSF) stimulate 
the bone marrow to produce granulocytes and stem cells and to subsequently release 
them into the circulating blood. [96]  The circulating stem cells and granulocytes are then 
recruited to the sites of tissue injuries by the locally up-regulated chemokines.  Finally, 
MMPs may be delivered to promote remodeling of damaged tissues, a key step in the 
regeneration process.[97] Apart from these proteins and peptides, a variety of genes have 
also been delivered in to carry out some of the functions described above. 
A wide variety of delivery vehicles have been designed to deliver the various 
cytokines. The most commonly used delivery vehicles include polymeric microcarriers 
such as PLGA microparticles.[99] To encapsulate soluble factors into these particles, the 
soluble factors are often dissolved in the aqueous phase while the polymers are dissolved 
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in the organic phase.[99]  Phase separation subsequently allows the encapsulation of the 
soluble factors within the polymeric shells.  Following fabrication, the microcarriers are 
readily injectable into the target site due to their micron size. These particles are highly 
customizable and can be made into core-shell particles to sequentially release different 
soluble factors.[100]  The encapsulated molecules are then slowly released for periods of 
weeks to months through diffusion out of the microcarriers, and through the degradation 
of the polymeric shells.   
Another class of commonly used delivery vehicle is the hydrogels.[101-103]  With 
hydrogels, the soluble factors may be incorporated directly into polymer precursors 
before cross-linking of the hydrogel network is induced.[102, 103]  This method of 
encapsulation is usually applied when the cross-linking reaction to form hydrogel 
network is relatively mild.  Another way of encapsulating soluble factors into the 
hydrogel network involves swelling of pre-formed dehydrated hydrogel network in a 
small volume of the soluble factors solution.[103]  In this method, the bioactivity of the 
encapsulated substances is preserved independent of the initial cross-linking reaction.  
The drug-loaded hydrogels can be introduced into the body through direct injection of the 
soft gel or through the injection of the drug-loaded hydrogel precursors before inducing 
hydrogel formation in situ.  The encapsulated substances are usually released over hours 
to weeks depending on the type of hydrogels used.  The release of encapsulated 
substances is dependent on the swelling of the hydrogel and the degradation of the 
hydrogel network.[102, 103]  To increase retention time of the encapsulated soluble 
factors, they can be further conjugated to the polymer network through physical 
interactions or covalent tethering.[102, 103]  One of the main drawbacks of the hydrogel 
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delivery system is its low modulus.  Due to the low modulus of the hydrogel systems, the 
gels might be compressed by local tissue pressures or by the movement of the patient. 
This might result in premature release of the encapsulated substances. 
 While nanoparticles have been extensively researched for anti-cancer therapies, 
they have only been recently applied to tissue regeneration applications.  The use of 
nanoparticles has been shown to increase the plasma half-lives of soluble proteins, and 
the conjugation of targeting ligands onto nanoparticles can allow their targeted delivery 
to specific cells.[104]  Owing to the size of nanoparticles, they readily enter target cells 
by endocytosis.[105]  There are many different forms of nanoparticles that have been 
used for delivery for drugs and proteins.  These include liposomes, polymeric particles, 
metallic particles, and self-assembled particles.[106-109]  In a recent study, it was 
demonstrated that nanoparticles made from self-assembled fusion proteins comprising of 
elastin-like peptides and keratinocyte growth factor were able to localize to wounded 
dermis for wound-healing and skin regeneration.[109]  
The diverse range of delivery vehicles, with their unique attributes, provides a 
multitude of options for the delivery of various proteins and genes.  With these controlled 
delivery platforms, the provision of key molecules can be customized to meet the needs 
of important tissue regeneration events.   The combination of the controlled delivery 
platforms with tissue engineering scaffolds is likely to generate a synergistic effect on 
tissue regeneration and tissue engineering applications.  In the next section, the integrated 
application of scaffold cues and soluble factor cues will be discussed. 
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2.15 Integrated tissue engineering approaches 
In the earlier sections, we have discussed how both mechanical and soluble cues 
are important in regulating cellular activities and tissue repair.  In integrated tissue 
engineering approaches, scaffold cues are integrated with soluble factors cues to 
synergistically enhance tissue repair and regeneration.[110, 111]  This integrated tissue 
engineering approaches may take several forms.  In the simplest form of such integrated 
tissue engineering approaches, delivery vehicles such as growth factor-loaded 
microspheres have been incorporated into a variety of different scaffolds such as collagen 
sponges, silk fibroin scaffolds and poly(L-lactic acid) nano fibrous scaffolds to increase 
tissue vascularization and neogenesis in vivo.[112-114]  In the various studies, it was 
demonstrated that tissue healing was enhanced with the integrated platform as compared 
to control conditions with only the scaffold or the microparticles.  The incorporation of 
microparticles into these various scaffolds is relatively straightforward and usually 
involved the mixing of the microparticles with scaffold polymer precursors.[110, 112, 
113]  This strategy also allowed the scaffolds’ surface properties and soluble factor 
release kinetics to be tuned independently with different combinations of scaffolds and 
delivery vehicles.  However, despite the seemingly straightforward procedures, the 
incorporation of delivery vehicles into scaffolds is not without challenges.  For, instance, 
the use of incompatible materials may result in phase separation between delivery vehicle 
and scaffold.  Also, the addition of microparticles may complicate the fabrication of 
tissue engineering scaffolds.  This is especially true for fabrication processes that involve 
small openings and fine nozzles.  For example, the addition of microspheres into pre-
polymer solutions might hinder the electro-spinning of fibrous scaffolds.  Furthermore, 
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the material properties such as porosity and elastic modulus of the integrated construct 
might also be different from that of the blank scaffold.[115]  Not only that, the release 
kinetics of encapsulated drugs might also be altered due to the presence of an additional 
barrier i.e. the scaffold.  As many of these challenges can be circumvented through 
careful design and experimentation, it is crucial for researchers to be aware of these 
issues when incorporating delivery vehicles into existing scaffolds.   
Another approach to integrate soluble factor cues and scaffold mechanical cues 
would be to introduce the soluble factors directly into or onto the scaffolds.  For example, 
BMP-2 has been directly incorporated into poly(L-lactic acid) (PLLA) solutions for 
fabrication of electrospun fibrous scaffolds.[116]  In the study, it was shown that the 
addition of BMP-2 significantly improved the regeneration of a bone defect as compared 
to a blank PLLA fibrous scaffold.  Although the bypass of delivery vehicles omits several 
associated problems such as phase separation and clogging of nozzles, other concerns 
such as loss of protein bioactivity and limited control of protein release come into the 
picture. 
While most integrated tissue regeneration approaches involve the local 
combination of both soluble and mechanical cues, several studies have also introduced 
soluble and scaffold cues at different sites.  For instance, in one instance, the local 
delivery of tissue- promoting scaffolds at the infarct area had been coupled with the 
remote delivery of colony stimulating factors.[117]  In this study, the injection of colony 
stimulating factors promoted the production of stem cells in the bone marrow and the 
subsequent release of these cells into the circulating blood in a process termed stem cell 
mobilization.  These mobilized cells then preferentially migrate to the site of tissue injury 
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to augment tissue repair and regeneration.  While there are few prior studies adopting this 
strategy, such an approach is slowly gaining ground as it harnesses the body’s natural 
regeneration capacity.   
The design and application of these integrated platforms demonstrate significant 
progress in multi-disciplinary efforts integrating the areas of biology and biomaterial 
engineering.  It also represents a greater understanding and mimicry of the body’s natural 
regeneration processes.  The early research in these integrated approaches have yield 
promising results and revealed many new challenges to be overcome.  With further 
research and refinement, it is the hope that these platforms will eventually provide 
solutions to different medical challenges.  
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3 Materials and method 
This chapter describes all the materials, methods and the equipment used in this work.  
The overall experimental strategy in this work is presented in Fig. 3.1. 
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3.1 Overview of experimental scheme 
The experimental scheme in this work is presented in the overview (Fig. 3.1).  
The experiments were divided into two sections.  The first section involved generation of 
the cell-instructive scaffolds while the second section involved the synthesis of the 
controlled delivery vehicles.   
To generate the cell-instructive scaffolds, collagen gels were modified by 
different approaches.  The first approach involved cross-linking of collagen gel with bi-
functional PEG cross-linkers to increase bulk gel stiffness (Chapter 3.3).  In the second 
approach, the covalently cross-linked collagen gels were softened by partial digestion 
with MMPs (Chapter 3.18).  The final approach involved modification of the local 
rigidity of collagen fibers by changing the fiber bundle thickness.  This was achieved 
through regulation of the collagen gel structures by tuning thermodynamic driving force 
during collagen self-assembly (Chapter 3.3).  The modified cell-instructive collagen 
scaffolds were further used to control the malignancy of hepatocellular carcinoma cells 
(HCCs) (Chapter 3.11) and to control the activation state of fibroblasts (Chapter 3.12).   
The controlled delivery vehicles investigated in the second section were PEGDA-
poly(ethylene imine) (PEI) hydrogels synthesized through Michael reaction between 
PEGDA and PEI (Chapter 3.21).  These hydrogels were extensively tested before they 
were finally evaluated in vivo in a porcine model.   
In the subsequent chapters, all materials were obtained from Sigma-Aldrich 
unless otherwise specified.  
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Figure 3.1 Overall scheme of experiments. (i) Scaffold cues were regulated through the 
design and synthesis of cell-instructive collagen gels.  The collagen gels were modified by 
three different approaches.  The first method involved cross-linking of the collagen gel to 
increase bulk gel stiffness.  The second method involved partial digestion of cross-linked 
collagen gel to decrease bulk gel stiffness and the third method involved the increase of fiber 
thickness to increase the local rigidity of the fiber bundles.  The scaffolds were subsequently 
used to regulate malignancy of hepatocellular carcinoma cells and to control the activation state 
of fibroblasts.  (ii) Soluble factor cues were regulated through the design and synthesis of 
PEGDA-PEI controlled delivery hydrogels formed through the Michael reaction.   
3.2 Chemical cross-linking of collagen gels 
Pure collagen gels were synthesized by mixing pre-chilled collagen I solution (3 
mg/ml, Puramatrix), Dulbecco’s Modified Eagle Medium (DMEM) (Cellgro), and 
reconstituting solution in a ratio of 8:4:1.[118]  The reconstituting solution was a mixture 
of 0.26 M of sodium hydrogen carbonate, 0.2 M 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), and 0.04 N of sodium hydroxide. This mixture 
was subsequently incubated at 37 C for 4 hours to form 3D collagen hydrogels.  The 
chemically cross-linked collagen gels were designated collagen-PEG hydrogels.  To form 
collagen-PEG hydrogels, poly(ethylene glycol) di-(succinic acid N-hydroxysuccinimidyl 
ester) (PEG-diNHS) (Mw 446.36) was dissolved in dimethyl sulfoxide at a concentration 
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of 50 mg/ml.  The solution was then added to the collagen/DMEM/reconstituting solution 
mixture at a final PEG-diNHS to collagen mass ratio (MPEG1-COL) of 0.17 (E0 = 2.3 kPa) 
or 0.33 (E0 = 4.0 kPa) before incubation at 37 C for 4 hours  
3.3 Increasing fiber rigidity of collagen gel through thermodynamic control 
Pure collagen gels were synthesized as described in Chapter 3.2.  For the 
modification of collagen fiber rigidity, the size of fiber bundles was modified by 
thermodynamic control through the addition of PEG (Mw 7500).  Unlike the chemically 
cross-linked collagen gel, the PEG used for thermodynamic control did not have any 
reactive functional groups.  In this approach, the collagen gels modified through 
thermodynamic control were designated collagen/PEG gels.  To form the collagen/PEG 
gels, the PEG was dissolved in DI water at a concentration of 300 mg/ml. The solution 
was then added to the collagen/phosphate buffered saline (PBS)/reconstituting solution 
mixture at a final PEG to collagen mass ratio (MPEG2-COL) of 5, 10, or 25 before 
incubation at 37 °C for 1 hour.  In the above pre-gel solutions, the PBS volumes were 
adjusted to maintain constant total volume. 
3.4 Scanning electron microscope imaging of collagen gels 
Collagen and collagen/PEG gels were imaged by scanning electron microscope 
(SEM) to visualize the structural differences.  To maintain the structural integrity of the 
hydrogels, the hydrogels were subjected to serial dehydration using increasing 
concentrations of ethanol.  The dehydrated samples were then dried with CO2 in a critical 
point dryer (Balzers CPD 030) and sputter coated with platinum (JFC-1300, JEOL) 
before imaging with the SEM (JSM-5600VL, JEOL).  ImageJ software was used for the 
quantification of fiber diameters and the number of fibers measured per sample was no 
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less than 100.  The mesh size of the respective collagen hydrogels were measured using 
four images per condition with ImageJ.  The images were thresholded at 90 on an 8-bit 
image to distinguish surface fibers from fibers in deeper planes.  The images were then 
processed with the invert function and the particle analysis function was used to find and 
measure particles greater than 4 pixels.  
3.5 Mechanical characterization of collagen gels 
Collagen and collagen-PEG gels were cast in molds with thickness of 1 mm and 
diameter of 5 mm for measurement of the compressive Young’s modulus (E).  The 
hydrogels were compressed with a mechanical testing system (MTS Insight) at a rate of 
0.1 mm/min and the resultant stress was determined.  E was determined from the slope of 
the linear curve between stress and strain at the first 10 % of strain.  Four samples were 
measured per condition.   
The storage moduli (G’) of the collagen and collagen/PEG gels were measured by 
an ARG2 rheometer (TA Instruments).  The gels were allowed to form by pipetting the 
respective pre-gel solutions between parallel 40 mm steel plates.  Following incubation at 
37 °C, measurements were carried out using a pre-optimized setting with a frequency 
sweep characterization from 0.1 – 100 rad/s at 5 % strain. 
The average bending rigidities () of the fibers in collagen and collagen/PEG gels 
were calculated by using the MacKintosh model from the following equation[66]: 
          
     (1) 
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, where G’ is the storage modulus in Pa,  is the mesh size in µm, k is the Boltzmann 
constant and T is the temperature in K. 
The theoretical  was further calculated by assuming the fibers to be either 
continuous materials made up of fibrils with strong inter-fibril covalent cross-links, or 
bundles of free-sliding fibrils with no inter-fibril interactions[119].  Theoretical  was 
evaluated by using the following equation:[119] 
                   (2) 
, where E is the Young’s Modulus of collagen fibers obtained from literature in MPa and 
I is the geometry-dependent second moment of inertia.  
When the collagen fibers were assumed to be continuous materials made up with 
strong covalent cross-links, Icovalent was given by: 
          
   
 
  (3) 
, where R is the radius of the fiber in µm. 
When the collagen fibers were assumed to be bundles of free-sliding fibrils with no 
inter-fibril interactions, Ifree was given by: 
      
      
 
  (4) 
, where r is the radius of the constituting fibrils in µm and N is the number of fibrils in a 
single fiber cross-section. 
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3.6 Permeability assay of collagen gels 
Permeabilities of collagen and collagen-PEG gels were determined by determining 
diffusivities of macromolecules within the gels.  This was carried out by using 
fluorescence recovery after photobleaching (FRAP).  The FRAP experiments were 
performed on a multiphoton confocal microscope equipped with a FRAP module (Zeiss 
LSM 710).   Fluorescein isothiocynate (FITC)-dextran (40kDa) was incorporated into the 
gels as a fluorescent probe.  Three randomly selected circular spots, each with a diameter 
of 95 m, were photo-bleached with a short-pulsed 488 nm laser.  The bleaching 
iterations were adjusted so that the resulting fluorescence from the spot became 
approximately 60% of the original fluorescence.  The recovery of fluorescence intensity 
over time was measured, and the curve was fitted with the following equation: 
              

  
  (5) 
,where      
    
  
, F0 is the initial fluorescence before bleaching, F(t) is the fluorescence 
intensity over time,  is the recovery time constant, A is the initial fluorescence, and B is 
a modified Bessel function. 
The diffusion coefficients (D) of FITC-dextran within the respective gels were 
then calculated with the following equation: 
  
  
 
 (6) 
,where D is the diffusion coefficient of FITC-dextran (cm
2
/sec) and r is the radius of the 
cylindrical bleached spot. 
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3.7 Second-harmonic-generation confocal imaging of collagen gels 
Unfixed, hydrated collagen and collagen-PEG gels were imaged with a multi-
photon confocal microscope (Zeiss LSM 710) using the 900 nm laser.  SHG signals 
generated from the collagen-based gels were collected at half the excitation wavelength.  
The SHG imaging was carried out using the 25x lens with water immersion.  Five images 
were obtained at 12 m intervals in the z-direction.  These images were then projected 
onto a single image using ImageJ software.   
3.8 Fourier transform infrared spectroscopy analysis of collagen gels 
Collagen and collagen/PEG gels were transferred to crystalline sample holders and 
analyzed with FTIR (Shimadzu FTIR-8400) for studying of amide bands positions (band 
positions A, B, I and II) in the absence and presence of PEG. 
3.9 Differential scanning calorimetric analysis of collagen gels 
The water content in the collagen and collagen/PEG gels was determined by a 
differential scanning calorimeter (DSC).  Water within the gel that melted at 0C was 
defined as free water while water that did not melt or melted below 0C due to 
interactions with the material was defined as bound water.  The amount of bound water in 
the collagen and collagen/PEG gels was calculated by examining the transition enthalpy 
of water in the respective pre-gels and gels.  To do so, the respective pre-gels and gels 
were heated in the DSC at a rate of 5 °C min
-1
 from -30 °C to 30 °C and the total amount 
of bound water were calculated.  In the DSC experiment, both freezing free water (Wff) 
and freezing bound water (Wfb) was regarded as freezable water (Wft).  Wff and Wfb can be 
calculated from the following equations: [120] 
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 (7) 
    
    
  
 (8) 
, where Wff is freezable free water, Wfb is freezable bound water, H is the transition 
enthalpy of water, qT=0 is the amount of heat loss at 0 C during melting as measured with 
the DSC and qT<0 is the amount of heat loss at temperatures less than 0 C during melting 
as measured with the DSC.   
3.10 Calculation of theoretical fiber diameters in collagen/PEG gels 
The theoretical fiber diameters at different MPEG2-COL were predicted by 
considering the amounts of bound water and the theoretical amounts of water bound to 
the PEG chains.  In these calculations, it was assumed that the moles of bounds of water 
bound to collagen fibers (nci) would be directly proportional to the total surface area of 
the formed fiber bundles (Ai) (where subscript i denotes the respective MPEG2-COL).  By 
estimating nci for different MPEG-COL, it was then possible to calculate the respective Ai 
and thus the predicted fiber diameters (di).  A good agreement between predicted and 
actual di would indicate that that the structures of the PEG-containing collagen gels were 
controlled by the amounts of bound water i.e. the relative water entropies.  For pure 
collagen gel (MPEG-COL = 0) with known mean fiber diameter, D: 
                                                (9) 
, where nbw0 is the total moles of bound water in collagen gel determined from DSC 
measurements. 
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Following some algebraic manipulation, the total surface area of the fibers in pure 
collagen gel could be simplified into the following equation: 
    
    
 
  (10) 
, where mc is the known mass of collagen in mg, υ is the known specific volume of 
collagen in µm
3
/mg and D is the actual mean fiber diameter in µm. 
Assuming direct proportionality of nci to Ai, 
 
   
  
 
   
  
 
   
  
 
    
   
 
    
   
    (11) 
, where subscript i denotes the respective MPEG2-COL 
The moles of water bound to collagen fibers in the respective conditions can be readily 
calculated from the following equation: 
                   (12) 
, (for i = 5, 10, 25) where nbwi is the total moles of bound water in the respective gels 
determined from DSC measurements and npi is the moles of water bound to PEG chains 
(calculated from mass of PEG by assuming 3 water/ ether group)[121]. 
Thus, the predicted diameters of the fibers in the respective gels could be calculated from 
the following equations: 
     
  
   
            (13) 
    
    
  
 (14) 
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 , (for i = 5, 10, 25). 
3.11 Cell seeding of HepG2 
Human hepatocyte cell lines HepG2 (ATCC) was cultured in DMEM 
supplemented with 10 % (v/v) FBS and 1 % (v/v) penicillin-streptomycin (PS, Gibco).  
The cells were maintained in T-75 flasks at 37 C in a 5% CO2 and 95% relative 
humidity environment. The medium was renewed once every 3 days and the cells were 
passaged once a week.  For encapsulation of the cells in collagen and collagen-PEG gels, 
cells were trypsinized and re-suspended in DMEM.  The cell suspension was then mixed 
with collagen and reconstituting solutions with a ratio of 4:8:1 for the pure collagen 
hydrogel; 0.17 and 0.33 mg PEG-diNHS/mg collagen were added to generate collagen-
PEG hydrogels with different elastic moduli.  The final cell density in all gel conditions 
was kept constant at 1  103 cells/L.  50 µL of the pre-gel solution was then dispensed 
into each well of a 96 well plate, with each well containing a total of 5 × 10
4
 cells.  After 
incubation for 4 hours to allow hydrogel formation, 100 µL of cell culture media was 
added to each well.  Media was exchanged with fresh media every three days.  
 To generate spheroids by the rocking method, 2  104 HepG2 cells were seeded in 
35 mm petri dishes.  The cells were rocked on a plate shaker at 60 rpm overnight.  The 
spheroids formed were then isolated by gentle centrifugation and were further 
encapsulated in collagen or collagen-PEG gels for 3 days. 
3.12 Cell seeding of fibroblasts 
Mouse fibroblast cell lines L929 (ATCC) was cultured in DMEM supplemented 
with 10 % (v/v) FBS and 1 % (v/v) PS.  The cells were maintained in T-75 flasks at 37 
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C in a 5% CO2 and 95% relative humidity environment. The medium was renewed once 
every 3 days and the cells were passaged once a week.  Prior to cell encapsulation, cells 
were trypsinized and re-suspended in DMEM.  The cell suspension was then mixed with 
collagen and reconstituting solutions in the ratios described earlier to form PEG-free pure 
collagen hydrogels or collagen/PEG hydrogels. The final cell density in all gel conditions 
was kept constant at 500 cells/L.  80 µL of the pre-gel solution was then dispensed into 
each well of a Transwell-24 well plate (Corning).  After incubation for an hour to allow 
hydrogel formation, the samples were rinsed thrice by pipetting PBS into the lower 
chamber of each well and allowing the solutions to gradually flow into the transwell 
inserts.  This was to prevent accidental disruption of the fragile gels.  Following which, 
1500 µL of DMEM containing FBS and PS was added to the lower chamber of each well.  
Media was exchanged with fresh media once every three days. 
For control experiments, L929 cells encapsulated in pure collagen gels were 
subsequently incubated in the both PEG-free and PEG-containing media for a period of 3 
days.  The cells were cultured in PEG-free media for another 3 days before their 
morphologies were studied. 
3.13 Cytotoxicity assays 
To evaluate the cytotoxicity of PEG-diNHS and PEG, HepG2 and L929 cell lines 
were plated in 96 well plates and incubated with DMEM containing PEG-diNHS and 
PEG respectively.  The concentrations of PEG-diNHS and PEG were similar to the 
concentrations used in the gels.  The viability of the cells were evaluated after 2 days by 
the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
according to the manufacturer’s protocol. 
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3.14 Total DNA quantification 
Cell proliferation of HepG2 was determined by counting number of cells through 
total DNA assays.  At fixed time points, gels were degraded through the addition of 100 
g/mL collagenase (Invitrogen).  De-ionized water was then added to the isolated cells to 
bring about osmotic lysis of the cells.  The cell membranes were further disrupted by 
subjecting the lysed cells to 3 freeze-thaw cycles.  The samples were then incubated for 
30 minutes with 20 L of 10 g/mL bisbenzimide in pH 7.4 buffer containing 10 mM 
tris(hydroxymethyl)aminomethane hydrochloride (TRIS-HCl), 1 mM 
ethylenediaminetetraacetic acid (EDTA), and 0.2 M sodium chloride.  The fluorescence 
intensities, which are proportional to the total amount of DNA, were then determined 
using a microplate reader at 356 nm excitation and 470 nm emission and compared to a 
standard curve.   
3.15 Immunofluorescent staining and confocal imaging 
For confocal imaging of the HepG2 cells, HepG2 cells were fixed with 4 % 
paraformaldehyde and permeabilized with 0.5 % Triton-X after 9 days of culture.  The 
permeabilized cells were then blocked with 2 % (w/v) bovine serum albumin and 5 % 
(v/v) fetal calf serum (Gibco).  Following blocking, the cells were incubated with nuclear 
stain, 4',6-diamidino-2-phenylindole (DAPI, Invitrogen), and their respective antibodies.  
For imaging of actin filaments, phalloidin-Alexa 488(Invitrogen) was used.  For imaging 
of 1-integrin, mouse monoclonal 1-integrin antibody and goat polyclonal antibody 
conjugated with Cy5 (Abcam) were used as the primary and secondary antibodies 
respectively.  For imaging of E-cadherin, rabbit monoclonal E-cadherin antibody 
conjugated with Alexa 555 (Cell Signaling Technologies) was used.  After staining with 
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the respective antibodies, the samples were washed with phosphate buffered saline and 
imaged with the multi-photon confocal microscope (Zeiss LSM 710) using the 2-photon 
mode for phalloidin and the single-photon mode for 1-integrin and E-cadherin imaging.  
For quantification of the size of nuclei and spheroids, confocal images of cells 
encapsulated in various gels were obtained at a magnification of 20 and the dimensions 
of each aggregate or nucleus were measured by using ImageJ software.  For 
quantification of the E-cadherin expression level, confocal images of cells encapsulated 
in various gels were obtained at a magnification of 20 and the integrated pixel 
intensities of E-cadherin signals obtained from ImageJ were normalized by the total area 
of cells.  
For confocal imaging of L929 cells, the gels were fixed and blocked as before 
following 10 days of culture.  Following blocking, the cells were incubated with nuclear 
stain, Hoechst and Phalloidin-Tetramethylrhodamine B isothiocyanate for imaging of 
actin filaments.  After the staining, the samples were washed with PBS and imaged with 
the confocal microscope (Nikon C1).  For quantification of the actin level, confocal 
images of cells encapsulated in various gels were obtained at a magnification of 20 and 
the integrated pixel intensities of actin obtained from ImageJ were normalized by the 
total volume of cells.     
3.16 Cytochrome P450 assay 
For quantitative analysis of cytochrome P450 activity at different time points, cell 
culture media was aspirated at various time points and the cells were rinsed twice with 
PBS solution.  100 µL of PBS containing 5 µM 7-ethoxyresorufin and 20µM dicumarol 
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was added to the well before incubation in the dark for 30 minutes.  The fluorescence of 
the resorufin-containing supernatant was then determined with a microplate reader at 535 
nm excitation and 595 nm emission.  The cytochrome P450 detoxification activity of the 
different conditions were normalized with cell numbers obtained from the total DNA 
assay at different time points.   
For live imaging of cytochrome P450 activity, the cells in the various gels were 
incubated with 2 ml phenol-free DMEM containing 20 µM 7-ethoxyresorufin, 25 µM 
dicumarol, and 2 mM probenecid for 5 minutes.  Confocal microscopy was carried out 
using a 514 nm laser and emissions above 570 nm were collected.  Pinhole size was set at 
100 µm with a pixel dwell time of 1.6 µs.  The same settings were used to image and 
process all samples.  The fluorescence intensity was then converted to pseudo-color with 
ImageJ with a 256 color map.   
3.17 Urea detoxification assay 
The detoxification of ammonia by the HepG2 cells was quantified by a urea 
detoxification assay.  For quantification of urea levels at different time points, phenol-
free cell culture media was aspirated and quantified with a colorimetric urea detection kit 
(QuantiChrom) according to the manufacturer’s instructions. Absorbance was determined 
at 475 nm with a microplate reader and the values obtained were compared with a 
standard curve.  The urea detoxification activity was normalized by the cell number at 
different time points. 
54 
 
3.18 Matrix metalloproteinase degradation assay 
MMP-1 (Calbiochem) was activated by p-Aminophenylmercuric Acetate (APMA, 
Calbiochem) immediately prior to use.  Briefly, 12 L of 50mM of APMA in 0.5 N 
NaOH and 30 L of MMP-1 were added to 90 L of buffer solution (pH 7.5) comprised 
of 25 mM HEPES, 5 mM calcium chloride, and 20 % (v/v) glycerol.  The mixture was 
incubated at 37 C for 2 hours for MMP-1 activation, after which the activated MMP-1 
solution was brought up to 3 mL with DMEM solution.  The resulting solution was then 
added to collagen-PEG gels at a 2:1 volumetric ratio.  The gels were incubated for 0 h, 1 
h, 3 h, and 5 h respectively at 37 C before 3 rounds of washing with sterile PBS.  The 
washed gels were subsequently immersed in DMEM containing 10 % fetal bovine serum 
(FBS, Gibco) to inhibit any traces of MMP-1.  The MMP-1 treated gels were 
subsequently characterized through mechanical characterizations, permeability assays 
and SHG imaging as described above. 
To investigate effect of MMP-1 treatment on collagen-PEG encapsulated HepG2 
cells, HepG2 cells were cultured in collagen-PEG gels as described above.  Following 5 
days of culturing, the collagen-PEG gels were exposed to MMP-1 for 0 h, 1 h, 3 h and 5 h 
respectively as described above.  Following exposure to MMP-1, the gels and cells were 
washed three times with sterile PBS and the HepG2 cells were furthered cultured for 4 
days.  The cells were then examined with confocal imaging and cytochrome P450 assay 
as described above. 
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3.19 Evaluation of angiogenic activity 
VEGF secretion was quantified by analyzing collected cell culture media with a 
VEGF ELISA kit (R&D Systems).  Absorbance was determined with a microplate reader 
at 570 nm with wavelength correction at 450 nm.  The values obtained were compared 
with a standard curve.   
For evaluation of in vivo angiogenic activity, fertilized chicken eggs (Hy-Line W-
36) were purchased from the Poultry Research Farm at the University of Illinois (Urbana, 
IL).  The eggs were incubated at 37 C with 5 % CO2 and 65 % relative humidity.  On the 
8th day of gestation, a small hole (1 cm  1 cm) was created on top of each eggshell. 
After an additional day of incubation to acclimatize the embryos, collagen and collagen-
PEG gels containing 5  104 cells, prepared four hours before, were implanted on top of 
the chicken chorioallantoic membranes (CAMs) (2 eggs per condition).  The openings 
were covered with tape and the eggs were further incubated for 6 days.  During this 
period, images of the CAM implantations were taken using a S6E stereomicroscope 
(Leica) linked with a D-Lux E Camera (Leica).  All procedures were performed under 
sterile conditions.  After the 6-day incubation, the membranes were fixed with 10% 
neutral buffered formalin (NBF) for 20 hours.   The fixed membranes surrounding the gel 
disk (10 mm  10 mm) were cut out and the collected tissues were processed by paraffin 
embedding and -SMA staining to examine and quantify mature blood vessel formation.  
Images of the stained CAM cross-sections at the implant site were taken using a DIML 
inverted microscope (Leica) linked with a D-Lux E camera (Leica).  The images were 
then examined using ImageJ software to determine overall blood vessel densities.  The 
blood vessel densities were calculated as the average overall area of positively stained 
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blood vessels normalized to the total area of the tissue.  The number of vessels and their 
corresponding diameters were also measured and normalized to the area of the CAM 
membranes. 
3.20 Collagen gel contraction assay 
To evaluate the contraction of collagen and collagen/PEG gels by the L929 
fibroblasts, the final areas of the different gels were also tabulated after 10 days of culture 
and normalized by the initial gel areas to give the percentage gel shrinkage. 
3.21 Synthesis of PEGDA-PEI hydrogels 
The PEGDA-PEI hydrogels were prepared by mixing PEGDA (molecular weight 
(Mw) ≈ 400, Polysciences) and PEI (MW ≈ 2000).[122]  Both PEI with branched 
architecture and linear architecture were used.  The mixtures of PEGDA and PEI were 
placed between two glass plates separated by a 1 mm-spacer.  Hydrogel disks with 
diameters of 5 or 10 mm were punched out after the gel was formed.  Pure PEGDA 
hydrogels were also formed by mixing aqueous solutions of PEGDA with 0.01 % 
Irgacure 2959 and subsequently exposing the PEGDA solutions to UV light for 10 
minutes. 
3.22 NMR characterization of PEGDA-PEI hydrogels 
To examine the reaction between PEGDA and PEI, the 
1
H-NMR spectra of 
polymer precursors, and the degraded fragments of PEGDA-PEI hydrogels were 
collected using NMR (500MHz, Varian). 
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3.23 Mechanical characterization of PEGDA-PEI hydrogels 
The E of the PEGDA-PEI hydrogel disks were measured by the MTS testing 
system as described above. 
3.24 Swelling studies of PEGDA-PEI hydrogels 
The initial swelling ratios of the hydrogels (Q0) were quantified with the ratios 
between the mass of the hydrogel disks and that of the hydrogels dehydrated via 
lyophilization.  The initial number of cross-links (N0) was further calculated using the 
following equations according to rubber elasticity theory:[123] 
   
  
 
 
 
  
 (15) 
, where S is the shear modulus calculated from the slope of stress versus (-2 ˗ ) 
assuming the hydrogels followed an affined network model (: ratio of deformed height 
to original height) and Q  is the degree of swelling calculated from Eq. (16): 
     
  
  
 
 
  
  (16) 
, where Q is the degree of swelling, s is the density of water, and p is the density of 
polymer. 
3.25 Degradation studies of PEGDA-PEI 
To evaluate the degradation of PEGDA-PEI gels, hydrogels were incubated in 1 ml 
PBS (pH 7.4), and their changes in swelling ratios were recorded by measuring their 
masses until the disks were completely disintegrated.  The swelling ratio at time, t, (Qm) 
was normalized by the initial swelling ratio of the disks (Q0).  The increase in Qm of the 
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hydrogel over time was further fitted to Peppas’s model to calculate its degradation rate 
(k1) and swelling exponent (n):[124, 125]  
     
  
    
  (17) 
, where Q0 is the initial swelling ratio, Qm is the swelling ratio of hydrogel disks at time, t 
(min).  
The diffusivity (D) was further calculated from k1 and n using the following 
equation:[126] 
      
  
 
 
 
 (18) 
, where D is the diffusion coefficient of water in cm
2
s
-1
, r is the radius of the hydrogel 
disks in cm, and   
       
 , where T is the time expressed in s. 
3.26 Determination of number of unreacted amines 
The number of unreacted amines after hydrogel formation through Michael reaction 
between PEI and PEGDA was investigated by reaction with 2, 4, 6-
trinitrobenzenesulfonic acid (TNBS).  Briefly, hydrogel disks were degraded by reaction 
with 1 M sodium hydroxide to expose the unreacted amine groups.  The number of 
unreacted amines remaining after PEGDA-PEI crosslinking was then determined by a 15 
minute-incubation with TNBS in the presence of sodium bicarbonate buffer (0.01M, pH 
8.5).  At the end of the assay, the absorbance was measured at 335 nm with a microplate 
reader (Synergy HT Multi-Mode Microplate Reader, Biotek Instruments), and the 
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absorbance was converted to the number of unreacted amines using a calibration curve 
generated with different concentrations of PEI.    
3.27 Imaging of water diffusion into PEGDA-PEI hydrogels using magnetic 
resonance imaging (MRI) 
Imaging of water diffusion through hydrogel disks was carried out using 600 MHz 
Varian Unity/Inova nuclear magnetic resonance (NMR) spectrometer (14.1 T magnet) at 
room temperature.[127-129]  The maximum strength of the magnetic field gradient was 
90 G cm
-1
.  Each hydrogel disk (10 mm in diameter, 1 mm in thickness) was incubated in 
deionized water.  Then, the cross-sectional images of hydrogel disks through the middle 
were taken every 25 minutes by placing the swollen hydrogels in glass bottles which 
were inserted into a Radio Frequency (RF) coil for the measurements.  Spin echo multi-
slice (SEMS) pulse sequence was used to acquire resonance data, which were then 
converted into water density maps using VNMR 6.1C software.  For SEMS pulse 
sequence, the repetition time (TR) of 2 s and the echo time (TE) of 10 ms were used.  The 
field of view (FOV) was 1.5 x 1.5 cm with the slice thickness of 1 mm, and the image 
matrix was 256 x 256 pixels.  After acquiring the images, colors were added to the 
images to visualize the water density spectrum using ImageJ. 
3.28 Cytotoxicity assay of PEGDA-PEI hydrogels 
Toxicity of the PEGDA-PEI hydrogels was evaluated by implanting them on the 
CAMs of chicken embryos.  Fertilized chicken eggs (Hy-Line W-36) were purchased 
from the Poultry Research Farm at the University of Illinois (Urbana, IL).  The eggs were 
incubated at 37℃ with 5% CO2.  On the 8
th
 day of gestation, a small hole (1 cm x 1 cm) 
was created on top of each eggshell.  After an additional day of incubation to acclimatize 
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the embryos, different hydrogel disks (5 mm diameter, 1 mm thickness) were implanted 
on top of the CAMs  (5 eggs per condition).  After incubation for 7 days, the membranes 
were fixed with 10 % neutral buffered formalin (NBF) for 20 hours.  The fixed 
membrane surrounding the gel disk (10 mm x 10 mm) was cut out.  The collected tissue 
was processed for paraffin embedding, and the cross-sections were stained with standard 
Hematoxylin & Eosin (H&E) for histological analysis.   
3.29 In vitro protein release assay of PEGDA-PEI hydrogels 
Fluorescent bovine serum albumin (BSA, Invitrogen) was mixed with the aqueous 
PEI solutions prior to the cross-linking reaction with the PEGDA solutions.  Hydrogel 
disks with diameters of 5 mm were punched out and incubated in PBS at 37 °C. The PBS 
was exchanged with fresh media on a daily basis until the hydrogel disk was disintegrated.  
The fluorescence intensity from the BSA was measured with a microplate reader 
(Synergy HT Multi-Mode Microplate Reader, Biotek Instruments), and the amount of 
BSA released was back-calculated from the intensity using a calibration curve.  The 
masses of the BSA released following the initial lag period was further converted to the 
release rate (k2) and release exponent (m) using Ritger-Peppas equation:[124] 
  
 
    
  (19) 
, where Mt is the cumulative amount of BSA released at time t, M is the total amount of 
BSA released, k2 is the release constant, and m is the release exponent. 
3.30 In vivo drug release assay of PEGDA-PEI hydrogels 
To investigate in vivo drug release from PEGDA-PEI hydrogels in mice models,  
BSA was labeled with fluorescent IRDye
®
 800CW N-hydroxysuccinimide ester (Li-cor 
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Biosciences) according to the instructions provided in the IRDye Protein Labeling Kit 
(Li-cor Biosciences).  30 l of the mixture of fluorescent BSA and PBS or 30 l of the 
fluorescent BSA-encapsulated PEGDA-PEI pre-gel solution (i.e. 12.5 % PEGDA and 10 % 
PEI) was injected into the back of mice (3 months old female C57BL/6 mice).  The mice 
were anesthetized at different time points, and the injection sites and ears of the mice 
were imaged with the Odyssey Infrared Imaging System with Mousepod (Li-cor 
Biosciences).  The fluorescent intensities of the BSA in all the mice were processed using 
the same settings.  The fluorescence images were further superimposed with photos of the 
actual mice for clearer visualization.  All procedures on mice were performed with 
approval from the University of Illinois Institutional Animal Care and Use Committee 
(IACUC).   
3.31 Stem cell mobilization with PEGDA-PEI hydrogels 
To investigate the function of the PEGDA-PEI hydrogels, the hydrogels were used 
to mobilize stem cells in porcine models through release of porcine granulocyte colony 
stimulating factor (GCSF).  The GCSF was dissolved in PBS or encapsulated in 
hydrogels before delivery into pigs (3 month old female white landrace pigs weighing 
approximately 30 kg each) via intramuscular injection.  Conditions tested in this 
experiment included (i) Single bolus injection of 3 mL PBS containing 1.2 mg of GCSF 
(number of samples was one), (ii) Daily bolus injections of injection of 3 mL PBS 
containing 0.3 mg of GCSF (number of sample was one),  (iii) single injection of 3 mL 
blank PEGDA-PEI hydrogel i.e. 20 % PEGDA and 3.5 % PEI (number of sample was 
one), and (iv) single injection of 3 mL of PEGDA-PEI hydrogel containing 1.2 mg of 
GCSF (number of sample was three).  Blood samples were taken daily from the 
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brachiocehalic vein by atraumatic venipuncture and collected directly into EDTA-
containing vacutainer tubes.  Cell counts of the non-erythrocyte fraction were performed 
on a Beckman Coulter AcT10 hematology analyzer (Beckman Coulter).  At the end of 
the experiment, animals were sedated with a telozal-xylazine-ketamine cocktail and 
euthanized by an intravenous overdose injection of sodium pentobarbital.  All procedures 
on pigs were performed with approval from the University of Illinois Institutional Animal 
Care and Use Committee (IACUC).     
3.32 Statistical analysis 
Three samples were analyzed per condition unless otherwise specified.  One-way 
ANOVA was used when the number of conditions was more than 2.  Student t-tests were 
used to compare differences between pairs of conditions.  Data was considered 
significant for P values < 0.05. 
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4 Regulation of HCC malignancy through 
covalent modification of collagen scaffold 
As discussed in chapter 2, 3D collagen scaffolds with tunable stiffness can serve as useful 
tools to study the effects of stiffness on cell malignancy.  This chapter describes the 
alteration of collagen gel stiffness through covalent cross-linking with PEG-diNHS and 
the culture of HCC in pure collagen and cross-linked collagen (collagen-PEG) scaffolds.  
By controlling the bulk stiffness of the collagen hydrogels, we were able to control the 
malignancy of encapsulated HCC.  The work in this chapter addresses objectives 1 and 2 
described in chapter 1.  This work has been published in Biomaterials.[118] 
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4.1 Tuning stiffness of collagen gels through chemical cross-linking 
The elastic modulus (E) of the collagen hydrogel was controlled by incorporating 
varying amounts of PEG-diNHS into the pre-gel solution of collagen with a pH of 3.  The 
resultant collagen-PEG hydrogel was formed by adjusting the temperature and pH of the 
mixture of collagen and PEG-diNHS (Fig. 4.1).  No gel was formed either by changing 
the temperature and pH of pure PEG-diNHS solution.  The resulting hydrogel remained 
structurally stable over nine days.  As expected, increasing the mass ratio between PEG-
diNHS and collagen (MPEG1-COL) from 0 to 0.33 linearly increased the E of the hydrogel 
from 0.7 kPa to 4.0 kPa as evaluated from the mechanical testing system (Fig. 4.2).  Such 
variation in the elastic modulus was broad enough to encompass the stiffness of several 
soft tissues, including fat and liver.  Note that 0.7 kPa corresponded to the E of fat tissue, 
while 4.0 kPa corresponded to that of healthy liver.[130, 131] 
 
Figure 4.1 Control of collagen gel stiffness with PEG-diNHS.  The soft pure collagen gel was 
formed from self-association of collagen fibers.  Individual single collagen fibers consisted of 
multiple helical bundles of collagen fibrils.  These fibrils were prepared by increasing the pH of 
the collagen solution to induce self-assembly of collagen molecules.  Stiffness of the collagen gel 
was increased by introducing covalent cross-links between collagen fibrils and PEG-diNHS to 
form collagen-PEG gels.   
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Figure 4.2 Characterization of hydrogel stiffness.  Increasing the mass ratio between collagen 
and PEG-diNHS (MPEG1-COL) linearly increased the E of the hydrogel.  Differences between 
conditions were statistically significant.  (*P < 0.05)    
4.2 Second-harmonic-generation confocal imaging of cross-linked collagen gels 
As the non-centrosymmetric collagen fibrils possessed first hyperpolarizabilities 
large enough for SHG microscopy, SHG imaging allowed visualization of collagen fibrils 
without fixation or staining.[77]  As demonstrated by the positive SHG signals observed 
in all conditions, the supplemental chemical reaction between collagen and PEG-diNHS 
did not interfere with the formation of interconnected collagen fibrils (Fig. 4.3).  The 
SHG analysis also revealed that increased cross-linking with PEG-diNHS increased the 
homogeneity of the collagen gels but decreased the mesh size from 3 to 1 µm, quantified 
by the average spacing between the fibers (Fig. 4.4).     
 
Figure 4.3 SHG images of gels prepared at different MPEG1-COL demonstrated that incorporation 
of PEG-diNHS in collagen gels resulted in a more homogeneous distribution of fibers.  The inset 
in each image represented the magnified view of the region marked by the circle (scale bars 
represent 25 µm, inset magnified 2.5×). 
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Figure 4.4 Average spacing between collagen fibrils decreased from 3.1 µm to 1.0 µm as the 
MPEG1-COL increased from 0 to 0.33. 
4.3 Permeability assay of cross-linked collagen gels 
One major concern with covalently cross-linking 3D hydrogel scaffolds was the 
decrease in gel permeability with increased cross-linking.  Such decrease in gel 
permeability may result in reduced transport of nutrients and oxygen to the cells and 
result in compromised cell viability.  To investigate if the permeability of the covalently 
cross-linked collagen-PEG gels was significantly decreased, the diffusivities of 
fluorescein-conjugated dextran with molecular weights of 40 kDa within the hydrogels 
were evaluated by the FRAP assay.  In this assay, several spots on the dextran-containing 
hydrogels were photo-bleached and the time taken for the fluorescence to recover through 
diffusion of the dextran was monitored.  From the FRAP assays, the diffusivity (D) of 
fluorescein-conjugated dextran within the hydrogel could be calculated (Fig. 4.4).  D, 
quantified with the FRAP assay, slightly decreased with increasing E of the hydrogels, 
but the difference between conditions was not statistically significant.  In addition, the D 
were in the order of 10
-7
 cm
2
/sec, which was similar to that in native ECM.[132]  The 
insignificant decrease in the D of dextran could be attributed to the small changes in 
mesh size which were still within the same order of magnitude. 
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Figure 4.5 Change of permeability with stiffness. Increasing E caused a limited decrease of the 
D of fluorescent dextran within the hydrogel, as characterized with FRAP assay.  Differences 
between conditions were not statistically significant.   
4.4 Control of HCC morphology with bulk gel stiffness 
The collagen-PEG hydrogels with varied E but similar permeability were used to 
prepare 3D HCC spheroids.  HepG2 cells, used as model HCCs, were encapsulated in the 
hydrogel via an in situ cross-linking reaction.  According to experiments conducted using 
HepG2 cells cultured on a 2D cell culture plate, the difference in PEG-diNHS 
concentrations between conditions did not influence cellular viability or metabolic 
activity.  Cells encapsulated in the different hydrogels proliferated to form spheroids over 
time.  Interestingly, the frequency of the cell cycle, quantified by the increase of the 
cellular DNA mass, decreased with increasing E of the hydrogel (Fig. 4.6).  Within nine 
days, the cells encapsulated in the pure collagen gel with E of 0.7 kPa formed large and 
loosely packed malignant spheroids with diameters ranging from 30 to 330 m (Fig. 4.7).  
These cells also actively invaded the collagen gel, which is the typical behavior of 
malignant cancer cells.  In contrast, cells cultured in the collagen-PEG hydrogel with E of 
4.0 kPa formed small and compact spheroids with diameters ranging from 20 to 60 m 
(Fig. 4.7).  The small spheroids had good cell-cell interaction and resembled hepatoids, 
clusters of normal hepatocytes formed in 3D matrices.  
68 
 
 
Figure 4.6 Cell proliferation of HepG2. The extent of increases in the intracellular DNA during 
24 hours, which represents the frequency of cell division, was reduced with increasing E at given 
time points. (  bar represents the pure collagen gel with E of 0.7 kPa,  bar represents 
the collagen-PEG gel with E of 2.3 kPa, and   bar represents the collagen-PEG gel with E of 
4.0 kPa,  *P < 0.05).  The values and error bars represent averaged values of three samples and 
standard deviation, respectively. 
  
 
Figure 4.7 Morphology of HepG2. Spheroids formed within the pure collagen gel (E = 0.7 kPa; 
1
st
 row) were larger and more disorganized than those formed within the collagen-PEG gels (E = 
4.0 kPa; 2
nd
 row).  Intracellular actins were stained with phalloidin (green color), and nuclei were 
stained with DAPI (red color).  Images in (b) are magnified views of spheroids shown in (a). 
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4.5 Control of HCC phenotype with bulk gel stiffness 
Apart from the observable changes in spheroid morphology, hydrogel stiffness also 
influenced the morphology and gene expression of individual cells in the spheroids.  The 
average nuclear diameter of HepG2 cells increased from 8  0.9 to 10  1.2 µm with 
increasing E, thus indicating increasing intracellular tension,.[133, 134]  In addition, the 
HepG2 cells in the small hepatoid-like spheroids formed within the stiffer collagen-PEG 
gel displayed down-regulated 1-integrin expression and up-regulated E-cadherin 
expression compared to those in the larger spheroids developed within the softer collagen 
hydrogel (Fig. 4.8).   
It had been shown in previous studies that malignant cancer cells expressed higher 
levels of the 1-integrin.  In these studies, blocking of 1-integrin, mediator of cell 
adhesion to type I collagen, subsequently resulted in suppressed malignancy of the cancer 
cells and reverted the cells to a more benign phenotype.[135]  On the other hand, E-
cadherin receptors, which were essential for cell-cell adhesion, were often found to be 
down-regulated in cancerous cells.[136]  The E-cadherin receptors had also been shown 
to be crucial for liver-specific activities.[137]  Hence, decrease in E-cadherin expression 
was often associated with loss of hepatocyte-specific functions. 
The HCC spheroids formed within collagen-PEG hydrogels with different E also 
exhibited diverse levels of hepatocyte-specific activities, including those of cytochrome 
P450, and ammonia detoxification.  The cytochrome P450 detoxification level was 
evaluated with the cellular capacity to convert non-fluorescent 7-ethoxyresorufin into 
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fluorescent resorufin, while the ammonia detoxification level was assessed with the cells’ 
ability to convert toxic ammonia to urea.  
 
Figure 4.8 Cell surface receptors of HepG2. Spheroids grown in the collagen-PEG gels (E = 
4.0 kPa) displayed (a) lower 1-integrin expression (yellow)  and  (b) higher level of E-cadherin 
(blue) compared with those grown in the pure collagen gel (E = 0.7 kPa).  Cell nuclei were 
stained with DAPI (red).  (Scale bars represent 50 m.) 
 
The small hepatoid-like spheroids formed within the stiffer collagen-PEG 
hydrogels presented higher cytochrome P450 detoxification levels (Fig. 4.9) and greater 
ammonia detoxification activity (Fig. 4.10) compared to the large spheroids formed in the 
soft collagen hydrogels.  These liver-specific activities were known to be inversely 
related to the cell’s degree of malignancy.[138]  As such, the higher levels of liver-
specific detoxification activities in the stiffer collagen-PEG gel (E = 4.0 kPa) indicated 
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that the covalent cross-linking was not only able to change the morphology of the cancer 
cells but was also able to alter the cells’ phenotype. 
Figure 4.9 Cytochrome P450 detoxification activities of HepG2. (a) Spheroids formed within 
the collagen-PEG gel (E = 4.0 kPa) presented higher cytochrome P450 detoxification activity 
than those cultured within the pure collagen gel (E = 0.7 kPa).  The fluorescent images of the live 
cells were processed to present 256 pseudo-colors which represent the P450 activity level.  (Scale 
bars represent 50 m.) (b) The cytochrome P450 detoxification activity was elevated with 
increasing E at given time points.  (  bar represents the pure collagen gel with E of 0.7 kPa, 
 bar represents the collagen-PEG gel with E of 2.3 kPa, and   bar represents the 
collagen-PEG gel with E of 4.0 kPa.)  The values and error bars represent averaged values for 
three samples and standard deviation, respectively.   
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Figure 4.10 Ammonia detoxification of HepG2. The ammonia detoxification level also 
increased with increasing E. (*P <0.05.  bar represents the pure collagen gel with E of 0.7 
kPa,  bar represents the collagen-PEG gel with E of 2.3 kPa, and   bar represents the 
collagen-PEG gel with E of 4.0 kPa.)  The values and error bars represent averaged values for 
three samples and standard deviation, respectively.   
In contrast, hydrogel stiffness could not control the intercellular organization and 
phenotype of pre-made tumor spheroids.  In a control study, HepG2 cells suspended in 
media were constantly rocked overnight to generate spheroids.  The resulting spheroids 
displayed a large variance in size and shape.  Encapsulation of these pre-formed 
spheroids into hydrogels with varied E did not cause any significant morphological 
changes in the spheroids, as confirmed by limited changes in intercellular organization.  
The spheroids also presented limited P450 detoxification activities, regardless of 
hydrogel stiffness.  These results demonstrate that pre-made spheroids are less responsive 
to mechanical signals from the hydrogel matrix than those assembled in situ. 
4.6 Control of HCC angiogenic propensity with bulk gel stiffness 
HCC spheroids formed within hydrogels with differing E also exhibited different 
levels of angiogenic activity, which is directly proportional to malignancy.  Angiogenic 
activity was evaluated with the secretion of VEGF and in vivo blood vessel growth on 
embryonic CAMs.  To determine the total amount of VEGF secreted by HCC 
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encapsulated in different gels, the HCC-conditioned media were analyzed by a VEGF 
ELISA assay.  Greater VEGF secretion was found in large HCC spheroids formed within 
the softer collagen gel as compared to those cultured within the stiffer gels (Fig. 4.11).  to 
evaluate the in vivo angiogenic potential, the HCC spheroid-hydrogel constructs were 
implanted on CAMs of chicken embryos to examine their ability to stimulate the growth 
of vascular networks in vivo.  Following 6 days of incubation, the density and size of 
vessels in the different conditions were quantified.  As displayed in both the top view and 
the cross-section of CAMs stained with -SMA antibody, the HCC spheroids formed 
within the soft collagen gel stimulated greater growth of blood vessels into the implants 
than those created within the stiffer collagen-PEG hydrogel (Fig. 4.12).  Quantitative 
analysis of the images also confirmed that spheroids formed in the softer gel increased 
the size and number of blood vessels as compared to hepatoid-like spheroids formed in 
the stiffer hydrogel (Fig 4.12).  Taken together, these results indicate that the larger 
spheroids in the softer collagen gel displayed higher angiogenic activities both in vitro 
and in vivo.  The higher secretion of VEGF from the larger spheroids could be attributed 
to lowered oxygen tension due to increasing spheroid sizes.[139]  VEGF, together with 
other angiogenic factors secreted by the cells subsequently increase local vessel 
formation.  Previous studies have demonstrated that cancer cells with higher 
malignancies tended to promote greater degree of angiogenesis.  Hence, these 
observations, like the earlier findings, implied that increasing stiffness of 3D matrix from 
the range of fat (0.7 kPa) to liver (4.0 kPa) suppressed malignancy of liver cancer cells.  
One interesting finding from this in vivo study was the further change in 
morphology when hepatoids within collagen-PEG gels were tested in vivo.  While these 
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hepatoids were initially observed as spheroids in the confocal images, they had 
transformed into polarized structures with lumens when implanted on the CAMs (Fig. 4.7 
& Fig. 4.12).  This change in morphology could indicate further differentiation of the 
HCCs towards hepatocyte phenotype, as primary hepatocytes are normally polarized in 
the liver and are arranged around the bile ducts.           
 
Figure 4.11 The VEGF secretion of HepG2. The cellular VEGF secretion level was reduced by 
increasing E from 0.7 kPa to 4.0 kPa.  (  bar represents the pure collagen gel with E of 0.7 
kPa,  bar represents the collagen-PEG gel with E of 2.3 kPa, and   bar represents the 
collagen-PEG gel with E of 4.0 kPa.  *P < 0.05)    
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Figure 4.12 Angiogenesis of HepG2. (a) HepG2 cells were encapsulated in pure collagen 
(MPEG1-COL = 0) with E of 0.7 kPa and collagen-PEG gels (MPEG1-COL = 0.33) with E of 4.0 kPa. 
Top view and cross-section images exhibit vascular networks formed near the gel constructs 6 
days post-implantation.  Blood vessels in the cross-section were stained by the antibody to α-
SMA (brown).  The red arrows denote the blood vessels while the dotted circles denote the 
HepG2 cell clusters.  HepG2 cells in collagen-PEG transformed into polarized structures with 
lumens when implanted on the CAMs. (Scale bars represent 50 m.)  (b)  Blood vessel density 
(quantified by normalizing the area stained by -SMA antibody with total tissue area) was 
significantly higher with implantation of the malignant spheroids formed within the pure collagen 
gel than either the acellular collagen gel or the hepatoids in the collagen-PEG gel (*P < 0.05).  (c) 
The malignant spheroids in the pure collagen gel also generated more and larger blood vessels. 
(  bar represents the pure collagen gel with E of 0.7 kPa,  bar represents the collagen-
PEG gel with E of 4.0 kPa, and bar represents the acellular pure collagen gel with E of 0.7 
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kPa.) 
 
4.7 Discussion on regulation of HCC malignancy through covalent modification of 
collagen scaffold 
Taken together, the experiments in this study successfully demonstrated a strategy 
to assemble 3D liver tumor spheroids with controlled intercellular organization, 
phenotype, and angiogenic activity.  This successful 3D spheroid assembly was achieved 
with cell-instructive hydrogels formed by inter-fibril and inter-fiber crosslinking of 
collagen with PEG-diNHS to control its stiffness.  The HCCs encapsulated in a fat-like 
soft hydrogel formed large and malignant spheroids characterized with active 1-integrin 
expression, cell proliferation, VEGF expression, and microvascular development, along 
with limited hepatocyte-like activities.  In contrast, the cells encapsulated in a normal 
liver-like stiffer hydrogel formed small spheroids with suppressed malignancy, 
characterized by hepatocyte-like phenotypes and limited microvascular development.   
When these cells were implanted in vivo, they were further transformed into polarized 
luminal structures. This indicated greater resemblance to healthy hepatocytes. 
The matrix design developed in this study allowed us to control the stiffness of a 
fibrillar matrix without significantly altering other matrix properties, including 
permeability and the number of cell adhesion motifs.  The range of elastic moduli 
achieved with this approach was relevant to liver physiology, because it encompassed the 
elastic moduli of fat and normal liver tissue.[130, 131]  The SHG images, which revealed 
the interconnected fibrous architecture of collagen-PEG hydrogels, showed that PEG 
molecules minimally influenced self-organization among collagen fibrils.  The short PEG 
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cross-linker was chosen to mostly localize the chemical reaction between collagen and 
PEG-diNHS within the collagen fibers.  This local stiffening of collagen fibers with PEG-
diNHS only resulted in slight decrease in both the spacing between collagen fibers and 
the molecular diffusivity within the gel.  The molecular diffusivity attained with the 
collagen-PEG hydrogels prepared in this study was similar to that within the native ECM.  
It was also larger by 2 to 4 orders of magnitude than the molecular diffusivity within the 
synthetic hydrogels commonly used for 3D cell culture.[140]  Therefore, the effects of 
gel permeability on cellular activities should be minimal in this study.  
We propose that the range of moduli achieved was vital to engineering tumor 
spheroids with various levels of malignancy, characterized by cell proliferation, 
detoxification activities, and proangiogenic activities.  We found that the softer matrix, 
similar to fat tissue, facilitated cellular adhesion to the matrix, represented by increased 
1-integrin levels, while the stiffer matrix, similar to normal liver, promoted cellular 
adhesion to neighboring cells, represented by higher E-cadherin levels.  Therefore, we 
suggest that deviations from normal liver stiffness altered integrin signaling and resulted 
in downstream signaling changes.  The deviation from normal liver stiffness also 
stimulated cell proliferation while down-regulating cellular ability to detoxify metabolites, 
characteristic of malignant phenotypes.  The resulting large spheroids, formed in the 
softer matrix, likely experienced limited oxygen transport.  This had been known to 
activate the cellular expression of VEGF driven by overexpression of hypoxia-inducible 
factors, which stimulated the development of tumor vascular networks in the spheroid-
hydrogel implants. [139]  In contrast, the cells in the small spheroids experienced only 
limited oxygen deprivation, leading to lower VEGF expression.  This cellular 
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responsiveness to matrix stiffness was observed only when the cells were individually 
encapsulated in the hydrogels.  The pre-made spheroids exhibited insensitivity to matrix 
stiffness.   
Another interesting finding was that the cellular response to matrix stiffness 
reported in this study differed from previous studies.  Certain studies conducted using 
breast cancer cells, previously reported that cells cultured on and within a gel stiffer than 
normal breast tissue exhibited an elevated malignant phenotype.[51]
 
  However, the E of 
the normal breast tissue was closer to that of the pure collagen gel used in this study.  
Therefore, these opposing results may indicate that malignancy was not merely a function 
of increase or decrease in stiffness but was promoted by departure from normal tissue 
stiffness.  However, this perspective needs to be explored more systematically in future 
studies.  Another key difference between this and other studies was the difference in 
culture format.  Many studies investigating the effect of matrix stiffness were conducted 
in the 2D configuration.[7]  On 2D substrates, cells tended to experience greater tension 
with increasing moduli.  When encapsulated in 3D gels however, the cells may 
experience greater compression instead of tension as a result of matrix stiffening.  It had 
been shown in previous studies that increasing tension led to increased cell proliferation, 
while greater compression tended to suppress cell proliferation.[42-44]  This highlighted 
the importance of generating 3D hydrogels with controllable stiffness such as the system 
presented in this chapter. 
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4.8 Conclusion on regulation of HCC malignancy through covalent modification 
of collagen scaffold 
This study demonstrated a novel strategy to regulate cellular organization and 
phenotype of 3D liver tumor spheroids.  This spheroid assembly was achieved with the 
cell-instructive hydrogels with controllable stiffness and limited changes in permeability.  
The tuned matrix stiffness allowed control of cellular adhesion to both matrix and 
neighboring cells and subsequently created 3D tumor spheroids with varied levels of 
malignancy.  We believe that this material design strategy can be readily extended to a 
wide array of fibrous hydrogels formed by self-association of different molecules such as 
oligopeptides and proteins.  In addition, the hydrogels developed in this study would be 
broadly useful to understand emergent behaviors of a wide range of stem and cancer cells.  
In the next chapter, we further investigated if the subsequent softening of stiff matrix led 
to changes in malignancy of encapsulated cells.  
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5 Regulation of HCC malignancy through MMP-
1 degradation of cross-linked collagen 
As demonstrated in chapter 4, increase of collagen hydrogel stiffness through covalent 
cross-linking suppressed malignancy of HCC.  This chapter describes thet reduction of 
hydrogel scaffold stiffness via MMP-1 degradation, resulting in the subsequent reversion 
of the HCC malignant phenotype.  The work in this chapter addresses objectives 3 and 4 
described in chapter 1.  
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5.1 Softening of cross-linked collagen gel through MMP-1 degradation 
The 3D cell culture studies in the earlier chapter demonstrated that pure collagen 
gels with E of 0.7 kPa created HCC spheroids with high malignancy while the collagen-
PEG gel with E of 4.0 kPa created HCC hepatoids with suppressed malignancy, as 
characterized by the changes in cell morphology, phenotype, and angiogenic activities.  
In this chapter, we investigated if the observed suppression of HCC malignancy by 
increasing matrix stiffness from fat-like range to liver-like range could be reverted with 
subsequent decrease in collagen-PEG stiffness.   
In order to decrease E of collagen-PEG hydrogels, we exposed the gels to low 
concentrations of MMP-1 for varied durations (Fig. 5.1).  The concentrations of MMP-1 
used for degradation had been shown in previous studies to only partially digest 
collagen.[141]  Following formation of the collagen-PEG hydrogels as earlier described, 
the collagen-PEG gels were incubated in MMP-1 solutions for periods of 0, 1, 3, or 5 h to 
degrade the collagen-PEG gels to varying degrees.  E of the treated gels were then 
quantified by compressive mechanical testing as described earlier.  As the period of 
MMP-1 exposure was increased from 0 h to 5 h, E of the hydrogel was decreased from 
4.0 to 0.5 kPa (Fig. 5.2).  These results demonstrated that the collagen-PEG gel (E = 4.0 
kPa) could be successfully softened to various degrees by varying digestion time.  This 
variation range of E (E = 4.0 kPa to E = 0.5 kPa) was also similar to that obtained by the 
covalent cross-linking of collagen (E = 0.7 kPa to E = 4.0 kPa).  Thus, this method of 
hydrogel softening was suitable for returning the stiffness of the cross-linked gel to its 
pre-cross-linked range.     
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Figure 5.1 MMP-1 degradation of collagen gels. The collagen-PEG gel (E = 4.0 kPa) was 
exposed to MMP-1 for varied durations, in order to soften the gels.  The concentrations of MMP-
1 used were previously shown to only partially digest the collagen fibrils.[141]   
 
 
Figure 5.2 Regulation of elastic modulus through MMP-1 degradation. Increasing duration of 
exposure to MMP-1 from 0 h to 5 h decreased elastic modulus (E) of the hydrogels from 4.0 kPa 
to 0.5 kPa.  The differences between the conditions were statistically significant. (*P < 0.0001) 
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5.2 Second-harmonic-generation confocal imaging of degraded collagen gels 
Apart from the mechanical characterization, the partial digestion of fibrils by 
MMP-1 degradation was also confirmed by SHG imaging.  As before, collagen-PEG 
hydrogels exposed to different durations of MMP-1 were imaged with SHG confocal 
imaging to visualize the SHG fibrils.  As the duration of exposure to MMP-1 increased, 
SHG signals corresponding to non-centrosymmetric fibrils decreased, implying loss of 
fibrils through enzymatic degradation (Fig. 5.3).  This was accompanied by increase in 
the average spacing between fibrils from 1.2 to 2.1 µm (Fig. 5.4). 
 
Figure 5.3 SHG images of MMP-1 degraded gels. SHG images of collagen-PEG gels following 
exposure to MMP-1 for varied durations.  The SHG signals decreased with increasing exposure to 
MMP-1.  The inset in each image represented the magnified view of the region marked by the 
circle (scale bars represent 25 µm, inset magnified 2.5×). 
 
 
Figure 5.4 Average spacing between collagen fibrils following MMP-1 degradation increased 
from 1.2 µm to 2.1 µm as the duration of exposure of collagen-PEG gels to MMP-1 increased. 
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5.3 Permeability assay of degraded collagen gels 
Due to the increased mesh size, the partial digestion of the collagen-PEG gels 
resulted in slight increase in the diffusion coefficients of dextran molecules from 15 to 23 
x 10
-8
 cm
2
/sec, as quantified with the FRAP assay (Fig. 5.5).  These changes were 
comparable to the change in permeability with covalent cross-linking of pure collagen 
gels.  The range of diffusivities observed was in the same order of magnitude as the 
diffusivities of proteins within native ECMs. 
 
Figure 5.5 Change of permeability following MMP-1 degradation. The diffusivity of dextran 
(D) within the collagen-PEG gel with E of 4.0 kPa was increased with increase in MMP-1 
exposure duration.   (*P < 0.0001) 
5.4 Control of HCC morphology through MMP degradation of gel 
We next examined whether the decrease of collagen-PEG hydrogel stiffness from 
4.0 to 0.5 kPa would trigger changes in morphology of hepatoid-like spheroids, formed in 
the stiff collagen-PEG hydrogel.  Following the formation of hepatoid-like spheroids in 
the stiff collagen-PEG hydrogel, the spheroid-hydrogel constructs were exposed to 
MMP-1 for varied durations (Fig. 5.6).  These constructs were then returned to normal 
cell culture media free of MMP-1 and further cultured for 4 days to observe the effect of 
matrix softening through MMP-1 degradation on tissue morphology.   
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Within 4 days, the cells in the gel degraded for 5 h (E = 0.5 kPa) invaded the 
matrix and proliferated extensively.  This generated large interconnected cell clusters 
with average span of 335 µm.  In contrast, the hepatoids in the undigested collagen-PEG 
gel (E = 4.0kPa) retained their size and compact morphology (Fig. 5.7).  The sizes of the 
cell clusters were proportional to the period of exposure to MMP-1.   
 
Figure 5.6 Scheme for MMP-1 degradation of HepG2-encapsulating collagen gels. HCC 
spheroids were formed by encapsulation in collagen-PEG (E = 4.0 kPa) for 5 days.  Then, the 
cell-encapsulating collagen-PEG hydrogel was incubated with MMP-1 for 0, 1, 3 or 5 hours.  The 
cells were further cultured in MMP-1-free media for 4 days.   
 
 
Figure 5.7 Morphology of HepG2 cells following MMP-1 degradation of collagen gels. The 
hepatoid-like HCC spheroids formed within the collagen-PEG gel became larger and more 
disorganized over 4 days after exposure to MMP-1.  The change in spheroid size and the degree 
of intercellular disorganization were dependent on the exposure duration to MMP-1.  The 
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intracellular actin was stained with fluorescent phalloidin (green) and nuclei were imaged with 
DAPI (red).  (Scale bars represent 50 µm)   
In order to examine if the differences observed were due to change in matrix 
properties and not a result of MMP-1 exposure, we incubated HepG2 cells cultured on 
tissue culture plate for varying durations with MMP-1.  When cultured on the tissue 
culture plate, exposure to MMP-1 for 0 h or 5 h did not result in any changes in cellular 
organization and cell growth rate.  This indicated that the changes observed were a result 
of changes in matrix properties.   
5.5 Control of HCC phenotype through MMP degradation of gel 
Apart from the changes in intercellular organization and cell proliferation with 
different degrees of collagen-PEG softening, the decrease in E of the hydrogel from 4.0 
to 0.5 kPa also decreased the average diameter of the cell nucleus from 10  1.2 m to 8 
 0.8 m.  This implied that the cells responded to the softening of the matrix by 
lowering their intracellular tension.[133, 134]   The reduced hydrogel stiffness also 
elevated the cellular expression of 1-integrin (Fig. 5.8) while decreasing E-cadherin 
expression (Fig. 5.8).  As mentioned in the earlier chapter, higher β1-integrin expression 
had been associated with increased malignancy, while decrease in E-cadherin expression 
had been associated with both malignant transformation and loss of hepatocyte-specific 
functions.[135-137]     
To determine if the softening of collagen-PEG gel subsequently resulted in a 
change of hepatocyte-specific activity, the cytochrome P450 detoxification activities of 
the encapsulated HCC were subsequently examined.  It was found that without exposure 
to MMP-1, the HCC encapsulated in collagen-PEG gel retained high levels of 
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hepatocyte-specific cytochrome P450 activities.  However, when cultured in MMP-1-
softened collagen-PEG gels, the HCC exhibited much lower levels of cytochrome P450 
detoxification activities (Fig. 5.9).[138]  This indicated that the softening of the gel 
subsequently lowered the intracellular tension of the HCC and resulted in changes in 
gene expression and cellular activities.  
 
Figure 5.8 Cell surface receptors of HepG2 following MMP-1 degradation of collagen gels. 
Exposure of the collagen-PEG gel with spheroids to MMP-1 for 5 hours (a) increased expression 
of β1-integrin (yellow) and (b) decreased cellular expression of E-cadherin (blue). (Scale bars 
represent 50 m.) 
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Figure 5.9 Cytochrome P450 detoxification activities of HepG2 following MMP-1 
degradation of collagen gels. Exposure of the collagen-PEG gel with spheroids to MMP-1 for 5 
hours reduced the P450 detoxification activity (marked by 256 pseudo-color in images).  (Scale 
bars represent 50 m.) 
 
5.6 Discussion on regulation of HCC malignancy through MMP-1 degradation of 
cross-linked collagen 
The reduction of hydrogel stiffness was implemented by exposing the stiffer 
collagen-PEG hydrogel, within which the HCC spheroids with suppressed malignancy 
were formed, to MMP-1 for varied durations.  The exposure of collagen-PEG hydrogel to 
MMP-1 resulted in partial digestion of the collagen-PEG gels as shown from the SHG 
images and achieved a range of matrix stiffness (E = 0.5 kPa) from normal liver stiffness 
(E= 4.0 kPa).  The softening of 3D matrix through MMP-1 exposure in turn altered 
intracellular tension as shown by the change in average nucleus diameter and promoted 
β1-integrin expression.[133-135]  We believe that these changes led to alteration of cell 
signaling and subsequently resulted in up-regulation of cell proliferation and reduction in 
hepatocyte-specific P450 activities.   
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The reversion of benign hepatoids in collagen-PEG gel (E = 4.0 kPa) to malignant 
phenotypes, following matrix softening further demonstrated that the cells are able to 
sense and respond to dynamic changes in their microenvironment.  This implied that our 
versatile platform, which allowed temporal control of matrix stiffness, would be a highly 
useful platform for studying the dynamics of malignant transformation.  Previous studies 
reported that local up-regulation of MMP may result in increase in cell malignancy.[142]  
However, the underlying mechanism had never been explained with respect to quantified 
changes in matrix stiffness.  Coupled with control studies in which HCCs were directly 
exposed to MMP-1, our results demonstrated that the elevation of cancer malignancy 
with MMP exposure could be related to matrix softening induced-cell signaling changes 
of top of other suggested pathways.   
5.7 Conclusion on regulation of HCC malignancy through MMP-1 degradation of 
cross-linked collagen 
Overall, this chapter demonstrated that benign hepatoids encapsulated in 3D gels 
with normal liver stiffness (E = 4.0 kPa) could be transformed to malignant phenotypes 
through MMP-1-induced matrix softening.  This was characterized by changes in cell 
morphology, proliferation and cell phenotype.  As this method of matrix softening 
allowed the E of the matrix and onset of softening to be controlled, this approach, 
together with the platform generated through covalent cross-linking of collagen, would 
serve as a highly useful tool for studying how dynamic changes in matrix stiffness affects 
cell malignancy.  
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6 Regulation of fibroblast activation state 
through thermodynamics-driven modification 
of collagen 
As discussed in chapter 2, apart from the bulk material stiffness of 3D scaffolds, the 
microstructure of the 3D scaffolds can also alter cell-integrin signaling and local 
material stiffness.  This chapter describes the control of collagen microstructure through 
the regulation of the thermodynamics-driving force during collagen self-assembly.  The 
varied microstructure and fiber stiffness, generated by adding free PEG chains to form 
collagen/PEG gels, was subsequently used to control the activation state of encapsulated 
fibroblasts.  The work in this chapter addresses objectives 5 and 6 described in chapter 1. 
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6.1 Increasing fiber diameter of collagen gel through thermodynamic control 
In the earlier chapter, bulk stiffness and architecture of collagen gels were altered 
by chemical cross-linking of collagen gels and MMP-1 degradation of collagen-PEG gels.  
Here, we report another method to control collagen gel fiber structure – via incorporation 
of free PEG chains to generate collagen/PEG gels.  Unlike previous studies where PEG 
was covalently conjugated to collagen to alter collagen gel properties, no chemical 
reaction between the collagen and PEG was required.   
Using this approach, we prepared collagen gels with different mass ratio of PEG 
chains to collagen (MPEG2-COL). Increasing MPEG2-COL from 0 to 25 led to a corresponding 
increase in mean size of fibers from 90 nm to 30 µm as shown in the SEM images (Fig 
6.1).  At MPEG2-COL = 25, we were able to generate gels with collagen fibers having 
similar fiber diameters as perimysial collagen cables surrounding muscle fibers (Fig. 
6.1).[143]  These features were not reproducible by chemically cross-linked control gels 
formed through reaction with bi-functional PEG-diNHS (Fig. 6.1).  The mean fiber 
diameters (d) increased in a fairly linear fashion with increasing PEG concentrations (Fig. 
6.2).  Similar to other studies, pure collagen gels (MPEG2-COL = 0) comprised almost 
exclusively of small fibers with diameters of approximately 90 nm.  These small fibers 
were present at all values of MPEG2-COL.  However, the proportion of small fibers 
decreased with increasing PEG concentration.  As the total collagen concentration 
remained constant in all the conditions, the mesh size () of the gels increased with 
increasing fiber thickness (Fig. 6.3).  However, the largest pores observed in the 
condition of MPEG2-COL = 25 were less than 5 µm.  This implied that cells are still able to 
interact with adjoining fibers.  
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Figure 6.1 SEM images of collagen gels. Increasing the mass ratio of PEG to collagen (MPEG2-
COL) resulted in the corresponding increase in thermodynamic driving force for self-association, 
thereby increasing the fiber diameters.  These images were obtained with SEM following critical 
point drying of the respective gels.  Pure collagen gels comprised exclusively of small fibers ( 
90 nm) while the PEG-containing gels comprised of a mixture of large and small fibers.  The 
fraction of small fibers decreased with increasing MPEG2-COL.  The collagen gels formed by 
thermodynamic control in had distinct architecture as compared to chemically cross-linked 
control gels formed by reaction with PEG-diNHS cross-linkers as shown above.  Also, the size of 
the collagen fiber bundles in MPEG-COL = 25 resembled that of perimysial collagen cables found in 
muscle as shown.  (*Image was obtained from study by Gillies, A. R. et. al.[143]) (Scale bars 
represent 1 µm, inset magnified 4×) 
 
 
Figure 6.2 Change in collagen fiber diameters. The increase in MPEG2-COL from 0 to 25 resulted 
in a corresponding increase in the mean fiber diameter (d) from approximately 90 nm to 30 µm in 
a linear fashion. (Bars represent standard error. 
#
Single-factor ANOVA test, α < 0.01) 
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Figure 6.3 Change in mesh size of collagen gels. The increase in MPEG2-COL from 0 to 25 also 
resulted in a corresponding increase in the mesh size () from approximately 1.0 µm to 2.1 µm in 
a linear fashion. (Bars represent standard error. 
#
Single-factor ANOVA test, α < 0.01) 
6.2 Mechanistic study of thermodynamic control 
To investigate the validity of our proposed mechanism, we carried out further 
characterizations with FTIR and DSC. FTIR was used to investigate if there was direct 
hydrogen bonding between collagen and PEG, while DSC was used to determine the 
relative proportions of freezable free water and un-freezable bound water, both before 
and after gelation.  A higher proportion of freezable free water would lead to a larger 
endothermic peak during melting of frozen water, while higher proportion of un-freezable 
bound water would lead to a smaller peak.[120]  The ratios of free water to bound water 
provided an indication of the relative entropies of the systems. Through FTIR analysis, 
we found that there was no shift in the amide bands of collagen gels after the 
incorporation of PEG (Table 6.1), thus demonstrating limited hydrogen bonding between 
collagen and PEG.  This lack of hydrogen bonding was also observed in previous studies 
involving polymer films cast from collagen and PEG.[144, 145]   
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 Amide band position [cm
-1
] 
A B I II 
Collagen 3326 3094 1654 1557 
Collagen + PEG 3327 3095 1656 1557 
Table 6.1 FTIR analysis of collagen and collagen/PEG gels. Amide bands of collagen showed 
limited shift after addition of PEG, thus indicating that hydrogen bonds were not formed between 
collagen and PEG. 
From the results of the DSC characterization, it was apparent that increase in 
MPEG2-COL resulted in the corresponding reduction of the endothermic peak in the pre-gel 
solutions (Fig. 6.4). This indicated larger ratios of bound water due to the increase in 
amount of hydrophilic PEG chains.  The increasing ratios of bound water to free water 
implied decreasing entropy with increasing MPEG2-COL.  However, following complete 
gelation, there were no longer differences in endothermic peaks with increase in MPEG2-
COL (Fig. 6.4).  This implied that the initial difference in entropies was normalized during 
the gelation process.   
A theoretical model was proposed to explain the underlying mechanism of 
structural control by incorporation of free PEG chains.  In pre-gel solutions, solubilized 
collagen molecules formed extensive hydrogen bonds with water. The water associated 
with collagen, termed bound water, decreased the overall entropy of the system due to 
their lowered motility. This unfavorable entropy provided a driving force for assembly of 
the solubilized collagen molecules into fibers bundles (Fig. 6.5).  During the self-
assembly of collagen, new hydrogen bonds between collagen were formed while 
hydrogen bonds between collagen and water were broken.  As the gain in entropy due to 
the freeing of water far outweighed the loss of entropy due to collagen association, 
favorable entropy was restored. When long PEG chains were introduced into the pre-gel 
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solution, the amount of bound water was further increased through hydrogen bonding 
with the hydrophilic PEG.  This resulted in even lower entropy in the pre-gel solutions, 
thus providing a larger driving force for collagen self-assembly.  The result was the 
formation of larger fiber bundles so as to restore entropy (Fig. 6.5).  With this proposed 
mechanism, the fiber diameter should be proportional to the mass ratio of MPEG2-COL, thus 
providing a simple way of controlling collagen fiber size and density in situ (Fig. 6.6). 
 
Figure 6.4 DSC characterization of collagen gels. Increasing MPEG2-COL from 0 (--) to 5 (--), 
10 (--) and 25 (--) resulted in the corresponding reduction of water’s melting endothermic 
peaks in pre-gel solutions.  This indicated that there was a smaller portion of freezable free water 
and a larger proportion of un-freezable bound water.  However, following complete self-
association of the collagen fibrils to form fibers, the melting endotherms were uniform for all 
MPEG2-COL from 0 (--) to 5 (--), 10 (--) and 25 (--).  This indicated that the initial 
disparity in bound water fraction and entropy was normalized by the different degree of self-
association between collagen fibrils. 
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Figure 6.5 Regulation of collagen fiber structure through thermodynamic control. (a) In pre-
gel solutions, solubilized collagen molecules formed extensive hydrogen bonds (H-bonds) with 
water (blue spheres).  The large proportion of H-bonded water, termed bound water (dotted), 
decreased the overall entropy of the system.  This low entropy provided the thermodynamic 
driving force to bring about association of collagen fibrils into collagen fiber bundles.  Collagen 
fiber formation subsequently decreased H-bonds with water, thereby reducing the fraction of 
bound water and restored overall entropy of the system.  (b)  With the incorporation of 
hydrophilic PEG chains (red spheres), the proportion of bound water in pre-gel solution further 
increased, creating a lower entropy.  This provided a larger thermodynamic force for self-
association of collagen fibrils in order for entropy to be restored.  As a result, the size of the 
resultant collagen fibers increased.   
 
Figure 6.6 Predicted change in fiber thickness with PEG content. Fiber thickness was 
expected to increase with increasing MPEG2-COL.  As the total collagen content was kept constant, 
the mesh size was expected to increase with increasing fiber thickness.  These trends were 
observed in the actual gels shown in Fig. 6.1. 
By considering the measured amounts of bound water and the theoretical amount of 
water bound to the PEG chains, we were able to predict the change in collagen fibers 
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diameters with change in MPEG-COL (Fig. 6.7, details of calculation presented in chapter 
3.10).  The good agreement of actual fiber diameter with predicted fiber diameter further 
indicated that change in entropy due to binding state of water was the dominant mode of 
structural control. 
 
Figure 6.7 Theoretical fibers of collagen gels. The theoretical fiber diameters were predicted by 
considering the amounts of bound water and the theoretical amounts of water bound to the PEG 
chains (•••).  The good agreement of actual d () and predicted d indicated that the suggested 
mechanism was the dominant mode of structural control of the PEG-containing collagen gels.   
 
6.3 Increasing fiber rigidity of collagen gel through thermodynamic control 
We further investigated the effect of PEG incorporation on bulk and local fiber 
mechanical properties.  The bulk mechanical properties were quantified through the 
measurement of storage moduli (G’) of the gels subjected to low-amplitude oscillatory 
shear deformation.  As MPEG2-COL was increased from 0 to 5 and 10, a corresponding 
decrease in G’ was observed (Fig. 6.8).  However, further increase of MPEG2-COL from 10 
to 25 resulted in a subsequent increase of G’.  This complex trend in G’ with varying 
MPEG2-COL could be attributed to the simultaneous changes in fiber diameter and 
porosity.[119]  According to the MacKintosh model, an increase in porosity was expected 
to result in the reduction of G’ while an increase in fiber diameter was expected to result 
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in the increase in G’.[119]  The G’ of pure PEG solution was almost zero, indicating that 
the incorporated PEG chains did not participate directly in the gel mechanics (Fig. 6.8).   
 
Figure 6.8 Storage modulus (G’) of the collagen gels displayed a complex trend with change in 
MPEG2-COL.  As MPEG2-COL was increased from 0 (--) to 5 (--) and 10 (--), the G’ decreased 
to a minimum. However, further increase of MPEG2-COL to 25 (--) resulted in an increase in G’.  
This complex relationship could be attributed to the concurrent changes in mesh size and single 
fiber rigidities with changes in MPEG2-COL.  Pure PEG solution   (--) had G’ of almost zero, 
indicating that the pure PEG solution did not participate in the gel mechanics. 
The individual fiber stiffness were quantified by determining the fiber bending 
rigidity (), calculated from the MacKintosh model from G’ and  (Fig. 6.9, equations 
presented in chapter 3.5).[66]  As expected, the  values increased with MPEG2-COL due to 
increasing fiber diameters.  These  values of the individual fibers fell within the 
theoretical  values calculated from their second moment of inertias.  To obtain the 
theoretical  values, the fibers bundles were either assumed to be continuous materials 
with strong covalent cross-links between comprising fibrils or assumed to be loose 
bundles of fibrils with no inter-fibril interactions (Fig. 6.9, equations presented in chapter 
3.5).[119]  In the former scenario, the theoretical  was much higher and scaled with the 
fourth power of fiber diameters.  However, in the latter case, individual fibrils were able 
to slide over each other, thus resulting in low  values.  As the actual  values fell 
between the two extremes but were closer to the second scenario, it was expected that the 
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fibrils within each fiber bundle should be able to slide over each other to some degree.  
However, their movements were restricted by hydrogen bonding between fibrils.   
 
Figure 6.9 Fiber bending rigidities () of collagen gels were estimated from the G’ and mesh 
size () of the respective gels with the MacKintosh model (--).  The values obtained were 
within the range of theoretical  calculated from the respective mean second moment of inertias.  
For the calculation of the theoretical, the fibers bundles were either assumed to be continuous 
materials made up of fibrils with strong covalent cross-links (•••) or bundles of free-sliding fibrils 
with no inter-fibril interactions (•••).  As the  values of the collagen gels fell between these two 
extreme models, it was expected that fibrils in the same fiber bundle were able to slide over each 
other to some degree.  However, this movement could be restricted by hydrogen bonding between 
fibrils. 
 
It had been shown in previous studies that cells were only able to sense the 
mechanical properties of the surrounding matrix within a couple of microns, thus 
indicating that encapsulated cells should be more greatly affected by local fiber 
mechanics than the overall mechanical properties.[146, 147]   Apart from the generation 
of unique gel architecture, another notable feature of this mode of control was the 
increase in mesh size with individual fiber rigidity.  The rigidity of hydrogels was 
conventionally increased by increasing either polymer concentration or cross-linking 
densities.[51, 148-150]  This typically led to decrease in mesh size and could be 
associated with compromised mass transfer and reduced viability of encapsulated 
cells.[151]  With the proposed method of gel synthesis, stiffer environments could be 
100 
 
introduced without reducing mesh size.  We postulate that in future studies, it should also 
be possible to vary fiber diameter while maintain constant mesh sizes by simultaneously 
tuning both collagen and PEG concentrations. 
6.4 Control of fibroblast morphology and phenotype with varied fiber rigidity 
Fibroblasts were incorporated into the collagen gels modified with varied MPEG2-
COL in order to examine the effects of modified fiber structures on cellular morphology 
and phenotype.  The cells were loaded into the different hydrogels by mixing them with 
pre-gel solutions and subsequently incubating the mixtures at physiological temperature 
and pH to activate gel formation.  As there were no covalent cross-linking between 
collagen and PEG, the gels were then washed to remove most of the PEG after gel 
formation.  Following culture for 10 days, cell morphology of the fibroblasts in the 
respective gels was examined.  The fibroblasts in pure collagen gels were spindle-shaped 
and formed an interconnected network with limited cell-cell adhesion.  This morphology 
was commonly observed when fibroblasts were cultured in soft cell-adhesive hydrogels.  
Conversely, fibroblasts in the collagen/PEG gel with thick fibers formed bundles with 
extensive cell-cell contact (Fig. 6.10).  These fibroblast bundles bear resemblance to 
contractile proto-myofibroblasts which were commonly found in healing wound 
tissues.[58, 152]  Such morphology was not found in control gels formed by PEG-diNHS 
chemical cross-linking (Fig. 6.10).  Apart from the change in appearance, the fibroblast 
in the collagen/PEG gels also displayed higher levels of actin, which was also commonly 
observed in proto-myofibroblasts (Fig. 6.11). [58, 152]  At the end of the culture period, 
the contractile functions of the fibroblasts in pure collagen gels and muscle-like gels were 
further examined by using a common wound healing assay, where the degree of gel 
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shrinkage between different conditions were compared.  After culture for 10 days, it was 
found that there was a greater shrinkage of the collagen/PEG gel as compared to its 
counterpart, indicating higher contractile function of the fibroblast bundles in the former 
(Fig. 6.12).  Taken together, the results demonstrated that the gels formed by 
thermodynamic control with free PEG chains were effective in instructing cell 
phenotypes.  By altering the fiber architecture, we were able to direct the fibroblast to 
adopt either a quiescent state or an activated, proto-myofibroblast state.   
 
Figure 6.10 Morphology of fibroblasts. Fibroblasts cultured within the respective gels for 10 
days were stained with Hoescht (red) to reveal the nuclei and with TRITC-phalloidin (green) to 
reveal the actin cytoskeleton.  Fibroblasts in pure collagen gels (MPEG2-COL = 0) were spindle-
shape and formed interconnected networks with limited cell-cell contact between individual cells.  
This was typical of collagen cultured in soft, cell-adhesive hydrogels.  However, when cultured in 
collagen/PEG gels (MPEG2-COL = 25) with thick collagen fibers resembling muscular collagen 
cables, the fibroblasts aggregated to form fibroblast bundles with extensive cell-cell contact.  
These fibroblasts resembled proto-myofibroblasts.  This phenotype was not observed in the PEG-
diNHS cross-linked control collagen-PEG gels (MPEG1-COL = 0.33). (Scale bars represent 50 m) 
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Figure 6.11 Actin levels of fibroblasts. The fibroblasts in the muscle-like collagen/PEG gel 
(MPEG2-COL = 25) had a higher level of normalized actin levels than fibroblasts cultured in pure 
collagen gel (MPEG2-COL = 0).  This up-regulation of actin was typical in activated fibroblasts or 
proto-myofibroblasts. (Bars represent standard error. *Student’s t-Test, α < 0.05) 
 
 
Figure 6.12 Contractile activity of fibroblasts. Following culture for 10 days, the fibroblasts in 
muscle-like collagen/PEG gels (MPEG2-COL = 25) contracted the gels extensively while no 
contraction was observed in pure collagen gels (MPEG2-COL = 0).  This indicated that the fibroblasts 
in the muscle-like gels had a highly contractile phenotype as compared to their counterpart in 
pure collagen gels.  (Bars represent standard error. *Student’s t-Test, α < 0.01) 
To confirm that the phenotypic changes observed were due to the differences in 
fiber structure rather than the initial presence of PEG, we further encapsulated fibroblasts 
in pure collagen gels and incubated the gels in PEG-containing media.  The addition of 
PEG after stable gel formation did not result in differences in fibroblast morphology or 
metabolic activity as characterized by the MTT assay (Fig. 6.13 & 6.14).  This 
demonstrated that the activation of the fibroblast was due to the change in fiber structure 
which took place during self-assembly rather than due to the presence of PEG.  We 
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propose that the observed phenotypic changes could be attributed to the increased 
stiffness of the individual fibers in collagen/PEG gels.  This observation was in line with 
previous studies which reported the activation of quiescent fibroblasts when cultured on 
substrates with increased rigidity.[153]  However, unlike the 2D studies, our 3D 
configuration allowed extensive reorganization and formation of bundles with good cell-
cell contacts.   
 
Figure 6.13 Effect of free PEG on fibroblast morphology. Fibroblast cells encapsulated in pure 
collagen gels were subsequently incubated in the both PEG-free and PEG-containing media for a 
period of 3 days.  The cells were cultured in PEG-free media for another 3 days before their 
morphologies were studied.  Fibroblasts in both conditions were spindle-shaped and had no 
observable differences, indicating that the differences in morphologies observed in the earlier 
experiments were due to change in fiber architectures and not due to the presence of PEG. (Scale 
bars represent 50 µm) 
 
Figure 6.14 Effect of free-PEG on fibroblast metabolic activity. Metabolic activity of 
fibroblast did not alter significantly after incubation with PEG solution for two days.  (Bars 
represent standard error. Student’s t-Test, p = 0.27) 
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6.5 Discussion on regulation of fibroblast activation state through 
thermodynamics-driven modification of collagen 
Here, we reported a novel method to generate unique collagen gel structures for 
cell instruction.  This was achieved by directing collagen self-assembly with free 
hydrophilic PEG chains.  With this method, the microstructures of three-dimensional 
collagen gels were readily controlled in terms of fiber size and density.  Increasing PEG 
content during collagen gel formation resulted in increasing fiber size and mesh size.  At 
MPEG2-COL = 25, we were able to form large collagen fiber bundles resembling perimysial 
collagen cables in muscles.  The collagen/PEG gels formed by non-covalent PEG 
modification had very different structures when compared to the collagen-PEG gels 
formed by PEG-diNHS cross-linking in chapter 4 due to the different underlying 
mechanisms of gel formation.  With the method of collagen modification presented in 
this chapter, we observed an increased mesh size with increasing fiber rigidities.  This 
was also different from the covalently cross-linked gel proposed in chapter 4.  As such, 
this method of collagen modification provided the added advantage of increasing local 
rigidities of fiber bundles without any decrease of mass transfer rates.  By using FTIR 
and DSC characterizations, we were able to provide evidence for the underlying 
mechanism of this PEG-mediated thermodynamic control.  We were also able to predict 
the changes in fiber structure with initial PEG content. 
Finally, we investigated the effects of these unique structures in cell-instructive 
collagen gels.  When fibroblasts were cultured in collagen/PEG gels resembling 
perimysial collagen cables, pronounced phenotypic changes occurred and quiescent 
fibroblasts were activated to form contractile proto-myofibroblast bundles.  These 
105 
 
morphological and phenotypic changes were not observed in Peg-diNHS cross-linked 
collagen-PEG gels.  Through further calculations, it was found that in the covalently 
cross-linked collagen-PEG gels presented in Chapter 4, despite increase in bulk moduli 
from E = 0.7 kPa to E = 4.0 kPa, the fiber rigidity decreased approximately ten-fold.  
This could be attributed to the thinner collagen fibers due to the more homogenous 
distribution in the presence of the PEG-diNHS short cross-linkers.  In the case of the 
collagen/PEG gel investigated in this chapter, despite a decrease in bulk storage modulus 
from G’ = 13.2 Pa to G’ = 8.3 Pa, fiber rigidity increased approximately nine-fold.  The 
differences in local and bulk rigidities of collagen-PEG and collagen/PEG gels 
demonstrated that apart from the overall stiffness of 3D scaffolds, the microstructures of 
the scaffolds also play very important roles in regulating cell activities.  This could 
probably be attributed to varied engagement of integrin with changes in gel 
microstructures.  Taken together, the collagen-PEG scaffold presented in chapters 4 and 5, 
and the collagen/PEG scaffold presented in chapter 6 were useful for different cell 
instruction purposes.   
6.6 Conclusion on regulation of fibroblast activation state through 
thermodynamics-driven modification of collagen 
In summary, through the incorporation of free PEG chains, we were able to 
generate unique gel structures not reproducible by chemical cross-linking.  We were also 
able to achieve increased substrate stiffness with increasing mesh size, which was 
opposite from the trend exhibited by conventional cross-linked gels.  This study was also 
the first to demonstrate that thermodynamic control could be used to generate unique 
cell-instructive scaffolds.  This mode of control could potentially be applied to other self-
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assembling gels such as peptide and fibrin.  Through the microstructuring mediated by 
thermodynamic control, we were able to provide the stimulation for fibroblast activation.  
As this was only a preliminary study to examine the feasibility of PEG-mediated 
thermodynamic control for generation of cell-instructive collagen gels, further 
characterizations in terms of gene and protein expression have to be carried out to study 
the underlying mechanisms. 
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7 PEGDA-PEI hydrogels with tunable 
mechanical and drug release properties 
On top of the microenvironmental cues covered in the earlier chapters, this chapter looks 
into the design of tailored drug release vehicles to enable better regulation of local 
soluble cues. This chapter presents a stiff and metastable poly(ethylene glycol) diacrylate 
(PEGDA)-poly(ethyleneimine) (PEI) hydrogel which exhibits an elastic modulus 
equivalent to bulk plastic materials, and controllable degradation rate independent of its 
initial elastic modulus.  Such unique stiffness allowed the hydrogel to resist local tissue 
pressures while releasing encapsulated drugs in a timely fashion.  With the PEGDA-PEI 
hydrogel, a single intramuscular administration of granulocyte colony stimulating factor 
(GCSF)-encapsulated hydrogel extended the mobilization of mononuclear cells to four 
days. Overall, the hydrogel created in this study will be useful for the controlled and 
sustained delivery of a wide array of drug molecules.  This work covers objective 7 
described in chapter 1. This work has been published in Biomaterials.[122]   
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7.1 Synthesis of PEGDA-PEI hydrogels 
The PEGDA-PEI hydrogels were formed through Michael reactions between the 
acrylate groups in PEGDA and primary and secondary amine groups in branched PEI 
(Fig. 7.1).  It was predicted that the highly branched PEI structure would contribute to the 
high stiffness of the PEGDA-PEI hydrogel, while the large number of protonatable amine 
groups on the PEI would contribute to water influx and timely drug release.  To prepare 
the hydrogels, PEGDA and PEI in separate syringes were mixed through syringe 
connectors.  Following mixing, the pre-gel solution was fluid and easily injectable.  This 
PEGDA-PEI mixture then set within a minute upon mixing and expulsion.  This allowed 
the PEGDA-PEI hydrogel to be retained at the site of injection. 
The Michael reaction between the acrylate groups of PEGDA and the amine 
groups of PEI was confirmed by the disappearance of acrylate peaks at 6.2 ppm in the 
1
H-NMR spectra of the hydrogel and the disintegrated hydrogel fragments (Fig. 7.2).  In 
contrast, mixtures of PEGDA and linear PEI did not form a hydrogel at similar 
concentrations.  Previously, several studies had reported the use of Michael reaction 
between PEGDA and PEI to prepare polymeric gene carriers in the form of nanoparticles.  
However, this was the first study in which the Michael reaction between PEGDA and PEI 
was used to form a bulk hydrogel.   
       
109 
 
 
Figure 7.1 PEGDA-PEI hydrogels were formed by Michael-type cross-linking reactions 
between the amine groups of branched PEI and the acrylate groups of PEGDA.  The highly 
branched structure of the PEI contributed to the high stiffness of the hydrogel while the 
protonated amines contributed to the high water influx. 
 
 
Figure 7.2
 1
H-NMR analysis of PEGDA-PEI hydrogels. 
1
H-NMR spectra of (a) pure PEGDA 
solution, (b) pure PEI solution, and (c) degradation products of the PEGDA-PEI hydrogel. The 
disappearance of peaks at 6.2 ppm in (c) indicated that acrylate groups in the PEGDA were 
consumed to form the hydrogel. 
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7.2 Tuning mechanical properties of PEGDA-PEI hydrogels 
Most conventional hydrogels were soft and had limited mechanical stiffness.  
However, a certain level of load-bearing capabilities was essential to prevent pre-mature 
release of encapsulated substances due to local tissue pressures.  The load-bearing 
capacities of the resulting hydrogels were evaluated by measuring the compressive elastic 
moduli (E) of the hydrogels formed with varied concentrations of PEGDA and PEI.  The 
initial compressive moduli (E0) of the PEGDA-PEI hydrogels were significantly 
increased with increasing concentrations of PEI at a constant PEGDA concentration of 
20 %, or with increasing concentrations of PEGDA at a constant PEI concentration of 10 % 
(Fig. 7.3).  Overall, E0 of the PEGDA-PEI hydrogels were controlled from 1 to 8 MPa, 
which were one to two orders of magnitude higher than elastic moduli of the pure 
PEGDA hydrogels formed from a radical cross-linking reaction (Fig. 7.3).  Strikingly, E0 
of the hydrogels consisting of 20 % PEGDA and 5 to 10 % PEI were comparable to the 
compressive modulus of poly(styrene) (~4 MPa) as provided by American Society for 
Testing Materials (ASTM).  The initial number of cross-links (N0) for the PEGDA-PEI 
hydrogels, calculated from the E0 and the initial swelling ratios (Q0) using rubber 
elasticity theory, was one order of magnitude higher than that of the pure PEGDA 
hydrogels formed from radical cross-linking reactions (Table 7.1).[123]   
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Figure 7.3 Initial compressive elastic moduli (E0) of PEGDA-PEI hydrogels were increased 
with PEI concentration at a given PEGDA concentration of 20 % ().  E0 of the PEGDA-PEI 
hydrogels were also increased with PEGDA concentration at a given PEI concentration of 10 % 
(), and the dependency of E0 on the PEGDA concentration was more significant than the 
radically cross-linked PEGDA hydrogels ().  The E0 value and error bar for each condition 
represent the average elastic modulus and the standard deviation from the measurements of four 
samples.   
 
10 % PEI 20 % PEGDA 0.01 % Irgacure 2959 
PEGDA 
(%) 
N0 (10
-5
 mol cm
-3
) PEGDA 
(%) 
N0 (10
-5
 mol cm
-3
) PEGDA 
(%) 
N0 (10
-5
 mol cm
-3
) 
12.5 2.59 3.5 1.01 12.5 0.09 
15 3.23 5 3.27 15 0.11 
20 3.55 10 4.51 20 0.24 
25 5.55 15 3.78 25 0.33 
Table 7.1 Cross-linking densities of PEGDA-PEI hydrogels. Initial number of cross-links (N0) 
of the PEGDA-PEI hydrogels was one to two orders of magnitudes higher than that of the 
radically cross-linked PEGDA hydrogel. 
7.3 Tuning degradation of PEGDA-PEI hydrogels 
In parallel, degradation rates of the PEGDA-PEI hydrogels incubated in neutral 
PBS were quantified by measuring the increase in swelling ratio (Qm) over time (Fig. 7.4).  
Initially, the swelling ratio increased without a decrease in solid mass.  However, as the 
swelling ratios reached higher values of about 10, the solid mass of the hydrogel disks 
started to decrease significantly.  Interestingly, the time required for complete structural 
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disintegration of the hydrogels decreased with increasing concentrations of PEI at a 
constant PEGDA concentration of 20 %, or with decreasing concentrations of PEGDA at 
a constant PEI concentration of 10 %.  The dependency of Qm on incubation time was 
fitted to calculate the degradation rate (k1), swelling exponent (n) and water diffusivity (D) 
(Table 7.2).  Increasing the PEI concentration at a constant PEGDA concentration of 20 % 
increased k1, n, and D.  In contrast, increasing the PEGDA concentration at a constant 
PEI concentration of 10 % significantly decreased k1, n and D.  These changes in k1, n, 
and D, resulting from changes in PEGDA concentrations or PEI concentrations, were 
related to the number of unreacted amine groups of PEI (Fig. 7.5).  Overall, increasing 
the PEGDA concentration at a constant PEI concentration resulted in an inverse 
dependency between D and E0, typical of conventional hydrogels (Fig. 7.6).  Conversely, 
increasing the PEI concentration at a constant PEGDA concentration resulted in increases 
of both D and E0 of the hydrogel, which is distinct from conventional biodegradable 
hydrogels (Fig. 7.6).     
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10 % PEI 
PEGDA (%) k1 N D 
(10
-5
 cm
2
s
-1
) 
Unreacted Amines 
(10
-6
 moles) 
12.5 0.32 0.97 94.8 1888 
15 0.28 0.92 72.3 1569 
20 0.21 0.86 42.8 1196 
25 0.18 0.78 23.3 892 
20 % PEGDA 
PEI (%) k1 N D 
(10
-5
 cm
2
s
-1
) 
Unreacted Amines 
(10
-6
 moles) 
3.5 0.05 0.66 1.9 0 
5 0.09 0.83 7.0 9.4 
10 0.21 0.86 42.8 1249 
15 0.22 0.92 49.2 2041 
Table 7.2 The swelling constants (k1), swelling exponents (n), and water diffusion 
coefficients (D) for different PEGDA-PEI hydrogel formulations were determined from 
logarithmic plots of Qm vs t (r
2
  0.97).  k1, n and D decreased with increasing PEGDA 
concentration at a given PEI concentration of 10 %, while they increased with increasing PEI 
concentration at a given PEGDA concentration of 20 %.  The moles of unreacted amines 
decreased with increasing PEGDA concentration at a given PEI concentration of 10 % and the 
moles of unreacted amines increased with increasing PEI concentration at a given PEGDA 
concentration of 20 %.  
 
Figure 7.4 The normalized swelling ratios (Qm) of the PEGDA-PEI hydrogels was also 
modulated by the PEGDA concentration which was increased from 12.5 % (), to 15% (), 
20 % () and 25 % (◓) at a given PEI concentration of 10 %. 
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Figure 7.5 Degradation rates (k1) of PEGDA-PEI hydrogels were increased with the number 
of unreacted amines, which were varied with PEI concentrations (◨) or PEGDA concentrations 
(◭) of the PEGDA-PEI hydrogels. 
 
 
Figure 7.6 Diffusivities within PEGDA-PEI hydrogels. Increasing the PEI concentration of the 
hydrogels at a given PEGDA concentration of 20 % resulted in the increase of both E0 and D ().  
In contrast, increasing the PEGDA concentration of the hydrogels at a given PEI concentration of 
10 % led to the inverse dependency between D and E0 (). 
The degradation process of the PEGDA-PEI hydrogel was further examined with 
MRI, which enabled the visualization of water protons that were bound to ("bound 
water"), and free from ("free water") the hydrogels (Fig. 7.7).[127]  It had been 
demonstrated that “bound water” presented much stronger signal intensity than “free 
water”.  Following imaging of the hydrogels, the resonance intensities in the MRI was 
converted to the color density map as shown in the scale bar (Fig. 7.7).  The pure 
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PEGDA hydrogel undergoing swelling in PBS showed a gradual increase of “bound 
water” volume as confirmed with the increase of yellow color intensity.  In contrast, the 
PEGDA-PEI hydrogel which rapidly swelled in PBS showed an initial increase “bound 
water” volume followed by the increase of the “free water” volume, as exhibited by the 
increase and subsequent decrease of yellow color intensity.  The increase of the ‘free 
water’ demonstrated the much higher water diffusivities in PEGDA-PEI hydrogels as 
compared to pure PEGDA hydrogels.  The rate of increase in the “free water” volume 
became larger with an increase in PEI concentration, which illustrated that the PEI drove 
the faster structural disintegration of the hydrogel by facilitating the accumulation of 
“free water” in the hydrogel.  
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Figure 7.7 MRI imaging of PEGDA-PEI hydrogels. Water sorption processes into (i) a 
hydrogel solely consisting of 20% PEGDA, (ii) a hydrogel consisting of 20% PEGDA and 3.5% 
PEI, and (iii) a hydrogel consisting of 20% PEGDA and 10% PEI were monitored using MRI.  
The MRI images were taken every 25 minutes after incubating the gel in deionized water.  White 
bars under the gel represent the original lengths of the hydrogels (10 mm).  The dotted lines in the 
MRI images represent the periphery of the hydrogels.  Scale bar on the bottom indicates the 
degree of interaction between water and hydrogels.  A high intensity of yellow color denotes 
strongly “bound” water molecules, whereas a low intensity of yellow color corresponds to “free” 
water molecule.  Pure PEGDA hydrogel (i) showed limited change of its original volume along 
with the gradual increase of the amount of “bound” water over time.  In contrast, the PEGDA-PEI 
hydrogels (ii and iii) showed the rapid increase of “free” water volumes over time and, 
consequently, the drastic increase of the hydrogel volumes. 
The degradation rates of the PEGDA-PEI hydrogels could also be tuned by 
extrinsic factors such as ionic strength of PBS.  Interestingly, the rate of water uptake of 
the PEGDA-PEI hydrogel was decreased with increasing ionic strengths of the PBS 
(Table 7.3).  Ultimately, increasing ionic strength of the PBS solution by 20 times 
induced the hydrogel’s swelling to reach an equilibrium state during the first 4 days of 
incubation.  These results suggest that increasing the ionic strength of PBS inhibited 
swelling of the hydrogel, likely because of the screening of the charged groups in PEI, 
and the elevation of osmotic efflux of water from the hydrogels.  
117 
 
Incubation 
solution 
Water uptake (mg/min) 
3.5 % PEI 10 % PEI 
1 PBS 0.081 1.87 
5 PBS 0.035 1.82 
10 PBS 0.029 1.55 
20 PBS 0.003 1.00 
Table 7.3 Swelling of PEGDA-PEI hydrogels in different ionic strengths. 3.5 % PEI and 10 % 
PEI hydrogels with fixed concentration of 20% PEGDA were immersed in solutions of different 
ionic strengths at 25 C.  Increasing ionic strength resulted in decreasing water uptake rates of the 
PEGDA-PEI hydrogels. 
7.4 In vitro drug release assay of PEGDA-PEI hydrogels 
Next, the effects of PEI concentrations on drug release profiles were examined by 
encapsulating fluorescently labeled BSA into the hydrogel (Fig. 7.8).  The encapsulation 
of the BSA into the PEGDA-PEI hydrogel decreased the degradation rate of the hydrogel.  
It was likely that electrostatic attraction between negatively charged BSA and amine 
groups of PEI slowed the degradation rate of the hydrogel.  This could be attributed to the 
decrease in the effective number of protonated amine groups.  However, the degradation 
rate of the hydrogel was still controlled by the concentration of PEI.  Specifically, the 
BSA was released from the hydrogels following a lag period (t1), which was extended 
from 1.0 to 6.5 days by decreasing the concentration of PEI (Table 7.4).  The release rate 
of BSA (k2), calculated in the chapter 3.29, was also increased with the concentration of 
the PEI.  The dependency of k2 on the degradation rate (k1) of the hydrogels indicated that 
the drug release kinetics from the PEGDA-PEI hydrogel was controlled by the 
degradation behavior of the hydrogel.  Together with the results of the MRI studies, it is 
likely that the degradation process of the hydrogel expanded the pores of the hydrogel 
and facilitated diffusion of BSA from the hydrogel.  
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Figure 7.8 The in vitro BSA release profiles from the PEGDA-PEI hydrogels were regulated 
by the concentrations of PEI.  The PEI concentration was changed from 3.5 % () to 5 % (), 
10 % () and 15 % (), while keeping the PEGDA concentration constant at 20 %. 
 
PEI (%) 
20 % PEGDA 
t1 (days) ln (k2) m 
3.5 6.27 -1.24 0.81 
5 1.28 -0.21 0.92 
10 0.01 11.03 2.15 
15 0.01 13.3 2.17 
Table 7.4 In vitro drug release constants of PEGDA-PEI hydrogels. The lag periods, 
quantified with time taken for 10% release of BSA (t1), drug release constants (k2), and release 
exponents (m) for different hydrogel formulations were determined from logarithmic plots of 
Mt/M vs t (r2  0.74).  k2 and m were regulated by the PEI concentrations at a given PEGDA 
concentration of 20 %. 
7.5 Cytotoxicity assay of PEGDA-PEI hydrogels 
Prior to the in vivo drug release experiments, the cytotoxicity and immunogenicity 
of the hydrogel fragments, resulting from the degradation process, were further examined 
by implanting hydrogel disks onto chicken chorioallantoic membranes (CAMs).  
Implantation of cytotoxic foreign substances on the CAMs would result in death of the 
chicken embryos while implantation of immunogenic foreign substances would result in 
extensive inflammatory responses.[154]  The hydrogels implanted on CAMs degraded at 
a rate comparable to the hydrogels incubated in PBS.  Following incubation for 6 days, it 
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was found that hydrogels containing less than 15 % PEI did not stimulate inflammation 
or present significant cytotoxicity (Fig. 7.9) 
 
Figure 7.9 Cytotoxicity and inflammatory response analysis of PEGDA-PEI hydrogels. (a) 
Top view of the CAMs captured right after and 6 days after implantation of (i) 20 % PEGDA 
hydrogel formed from photo cross-linking reaction, (ii) 20 % PEGDA-3.5 % PEI hydrogel 
formed from Michael cross-linking reaction, and (iii) 20 % PEGDA-10 % PEI hydrogel formed 
from Michael cross-linking reaction.  The photo cross-linked PEGDA hydrogel disk was still 
observed on day 6, whereas the PEGDA-PEI hydrogel disks completely disappeared. (b) Cross-
sections of CAMs on which the hydrogels corresponding to the above conditions were implanted.  
After 6 days, the CAMs were fixed and stained with Hematoxylin and Eosin.  Inflammatory cells 
were recruited to the site of implantation for all 3 conditions but more hyperplasia was observed 
on the CAM implanted with photo cross-linked PEGDA hydrogel as compared with the PEGDA-
PEI hydrogels.  The arrows in the photos represent the leukocytes recruited to the sites of 
implantation. (Scale bar corresponds to 100 µm)  (c) Percentages of chicken embryos that 
survived 6 days after the implantation was significantly increased as the PEI concentration of the 
PEGDA-PEI hydrogels were decreased from 15 % to 10 %.   
 
120 
 
7.6 In vivo drug release assay of PEGDA-PEI hydrogels 
 In addition, the BSA-encapsulated PEGDA-PEI hydrogel was subcutaneously 
injected into mouse models to examine the role of the hydrogels in the displacement of 
BSA from the injection site in vivo.  Unlike the in vitro studies, the initial elastic moduli 
of the hydrogels should also influence BSA’s displacement along with the degradation 
rate, because of the tissue pressures exerted on the hydrogels.  In this study, hydrogels 
used consisted of 12.5 % PEGDA and 10 % PEI.  These hydrogels had elastic moduli of 
approximately 4 MPa and degraded in less than a day in PBS solution.  The fluorescent 
BSA administered via bolus injection dispersed rapidly, as confirmed with the rapid 
decrease of fluorescence at the injection site within three days (Fig. 7.10).  In contrast, 
injection of the BSA-encapsulated PEGDA-PEI hydrogels slowed the spread of the BSA 
at the injection site as shown by the slower decrease of fluorescence over six days.  
Subsequently, the PEGDA-PEI hydrogels resulted in a smaller rate of decrease in 
circulating BSA, demonstrated by the slower change of fluorescence in the mice’s ears 
than bolus injection (Fig. 7.11).  Coupled with the in vitro BSA release study, this result 
clearly demonstrated that the PEGDA-PEI hydrogel enabled the systemic and sustained 
delivery of BSA.  The slower release of fluorescent BSA in the in vivo experiment could 
be attributed to the lower amounts of water present in the fat tissues.    
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Figure 7.10 In vivo release analysis of PEGDA-PEI hydrogels. (i) Bolus injection of the 
fluorescent BSA resulted in the rapid decrease of fluorescence at the injection site.  (ii) In 
contrast, injection of the BSA-encapsulated hydrogel consisting of 12.5 % PEGDA and 10 % PEI 
led to the sustained fluorescence at the injection site over six days.   
  
 
Figure 7.11 In vivo distribution of fluorescent BSA from PEGDA-PEI hydrogels. (a) 
Accumulation of fluorescently labeled BSA in the ears of mice administered with (i) bolus 
injection of fluorescent BSA and (ii) injection of BSA-encapsulated hydrogel formed from 
12.5 % PEGDA and 10 % PEI.  These images were captured at various time points over six days.  
(b) Normalized fluorescence intensities of BSA (I/I0) in ears of mice administered with the bolus 
injection of the fluorescent BSA () and the injection of the fluorescent BSA-encapsulated 
hydrogel formed from 10 % PEI and 12.5 % PEGDA ().  The fluorescence intensities peaked 
one day after the injections and declined much faster with the bolus condition. 
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7.7 Stem cell mobilization with PEGDA-PEI hydrogels 
Lastly, GCSF was encapsulated into hydrogels consisting of 20 % PEGDA and 
3.5 % PEI, which presented an initial elastic modulus of 3 MPa and released BSA more 
slowly than the hydrogel containing 10 % PEI.  As the GCSF with an isoelectric point 
between 5.8 and 6.6, would minimally interact with amine groups of PEI in a neutral 
condition, there would be insignificant decrease in the degradation rate of the hydrogel.  
The GCSF-encapsulated hydrogel was injected into the shoulder muscle of porcine test 
animals, where the load-bearing capacity of the hydrogels would also influence the 
release profiles of the GCSF along with the degradation rate.  The mixtures of PEGDA 
and PEI formed a stiff hydrogel right after injection of the pre-gel solution, similar to the 
gel formed in vitro (Fig. 7.12).  Injection of the GCSF-encapsulated hydrogels elevated 
the number of total number mononuclear cells in circulation one day after administration, 
and the number of cells was significantly greater than the injection of blank hydrogels 
without drug (Fig. 7.13).  The elevated mononuclear cell number was retained for 48 
hours followed by a gradual decrease over another 48 hours.  In contrast, bolus injection 
of the same dose of GCSF elevated the cell number one day after injection, with drastic 
decrease thereafter.  This rapid decrease could be attributed to the short half-life of GCSF 
which was reported to range from two to four hours.[155]  The positive control which 
comprised of repeated daily injections of GCSF for four days maintained an elevated 
mononuclear cell number over the same time period with a rapid decrease after the final 
day of injection.    
 The mononuclear cells collected on Day 4 were further cultured in endothelial 
growth medium to isolate and expand endothelial progenitor cells (EPCs) which were 
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important in ischemia therapies and for treatment of myocardial infarction (Fig. 7.14).  
Interestingly, in vitro expansion of mononuclear cells mobilized with GCSF-
encapsulating hydrogels produced a larger number of cells expressing CD34 and CD31 
antigens, markers of EPCs, as compared with mononuclear cells mobilized via single or 
repeated bolus injections of GCSF.    
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Figure 7.12 Bolus injection of PEGDA-PEI hydrogel. The hydrogel formed was stained blue 
for better visualization.  This demonstrated the localization of the encapsulated substance at the 
injection site. (Scale bar represents 1 cm) 
 
Figure 7.13 Stem cell mobilization with GSCF-encapsulated PEGDA-PEI hydrogels. GCSF 
solutions or GCSF-encapsulated PEGDA-PEI hydrogels were injected intramuscularly into pigs, 
and the number of mononuclear cells in the peripheral blood was monitored for four days. The 
graph represents the number of mononuclear cells over baseline during the course of the 
experiment.  The conditions tested were single injection of blank hydrogel (), single bolus 
injection of 1.2 mg of GCSF dissolved in PBS (), single injection of 1.2 mg of GCSF 
encapsulated within the hydrogel () and four daily bolus injections of 0.3mg of GCSF dissolved 
in PBS ().  Initial injections were given on day 0 and daily injections were continued to day 3.  
Injection of GCSF significantly increased the number of cells mobilized into circulation, but the 
time periods with sustained elevated cell number were mediated by the method of administering 
GCSF. 
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Figure 7.14 Mobilization cell population with GSCF-encapsulated PEGDA-PEI hydrogels. 
Circulating mononuclear cells were collected four days after initial injections and expanded in 
endothelial growth medium in vitro over three passages.  Cells expressing CD31, CD34, or both 
were identified using flow cytometry.  The conditions were (i) daily bolus injections of 0.3 mg of 
GCSF for four days, (ii) single injection of blank hydrogel, and (iii) single injection of 1.2 mg of 
GCSF encapsulated within the hydrogel.  The condition with administration of GCSF-
encapsulating hydrogel resulted in the largest fraction of culture-expanded cells expressing CD31 
and CD34 as compared with other conditions. 
7.8 Discussion on PEGDA-PEI hydrogels with tunable mechanical and drug 
release properties 
In this chapter, we developed PEGDA-PEI hydrogel through the Michael reaction 
between the primary and secondary amines groups in the hyper-branched PEI and the 
acrylate groups in the PEGDA. The PEGDA-PEI hydrogel presented initial stiffness high 
enough to maintain its structural integrity, so as to overcome local tissue pressures and to 
sequester the GCSF at the injected site.  In addition, the hydrogel was designed to 
degrade in a controlled manner, independent of its initial stiffness for sustained release of 
the encapsulated GCSF.  These properties were distinct from conventional hydrogel 
systems which were often plagued by limited controllability of stiffness and an inverse 
dependency of degradation rate on the initial rigidity.  Previously, certain efforts were 
made to develop structurally rigid hydrogel systems.  These include double network 
hydrogels, topological gels, nanocomposite gels and cryogels, all of which designed to 
exhibit elastic moduli comparable to hard cartilage tissues.[156-160]  However, these 
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hydrogels typically had limited degradation rates which precluded their use as drug-
releasing carriers.   The ease of degradability of the PEGDA-PEI hydrogel was attributed 
to the large number of amines on the PEI.  Amines which did not take part in the Michael 
reaction were protonated and drove the non-equilibrium swelling of the hydrogel.  By 
varying the mass fraction of PEGDA and PEI, the stiffness and degradation rate of the 
PEGDA-PEI hydrogel could be tuned independently.  
Although higher concentrations of PEI resulted in cytoxicity, PEI concentrations 
less than 15% presented limited cytotoxicity and immunogenicity.  The stem cell 
mobilization experiment also demonstrated that the stiff and metastable PEGDA-PEI 
hydrogels improved the efficacy of GCSF for mobilizing stem and progenitor cells.  
GCSF released stem and progenitor cells residing in the bone marrow by limiting the 
expression of chemokines involved in cell adhesion (e.g. stromal-cell derived factor 1) 
and also by stimulating the monocytes’ expression of matrix 
metalloproteinase.[155]  Because the GCSF administered into circulation had a half-life 
of two to four hours, the hydrogels could have a stabilizing effect on the GCSF, thus 
allowing for sustained mobilization as compared with the single bolus injection of 
GCSF.   Furthermore, the largest yield of CD34+ and CD31+ EPCs obtained from 
mononuclear cells mobilized with the GCSF-encapsulating hydrogel implied that 
sustained GCSF delivery promoted stem and progenitor cell mobilization while 
minimally stimulating inflammatory cells.  Conversely, bolus administration of GCSF 
significantly increased the number of inflammatory cells including neutrophils, 
monocytes, B cell, and dendritic cells in circulation.[161]  However, the underlying 
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mechanism for the enhanced efficiency of stem and progenitor cell mobilization needs to 
be studied more thoroughly in future studies.   
Although the PEGDA-PEI hydrogel had only been tested with BSA and GCSF, it 
has the potential to be combined with other drugs and cytokines due to its customizability.  
The PEGDA-PEI hydrogel could also be readily combined with the cell-instructive 
scaffolds to provide local regulation of both soluble and microenvironmental cues. 
7.9 Conclusion on PEGDA-PEI hydrogels with tunable mechanical and drug 
release properties 
Overall, the results of this study demonstrated that the stiff and metastable 
PEGDA-PEI hydrogels allowed the decoupled control of degradation rates and stiffness. 
This hydrogel system was successfully used as an injectable drug delivery system 
enabling sustained mobilization of stem and progenitor cells into circulation.  The unique 
stiffness of the hydrogel was attained from the highly branched architecture of PEI and 
the decoupled controllability of degradation rate was achieved by tuning the number of 
protonated amine groups of the hydrogel.  We therefore expect that the degradation rates 
of the hydrogels developed in this study may be further controlled over a broader range 
through chemical modification of PEI in the hydrogel so as to suit different delivery 
applications.  Due to its injectability and ease of application, this hydrogel could also be 
readily combined with cell-instructive scaffolds to generate integrated tissue engineering 
systems. 
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8 Conclusions and future prospects 
This chapter provides an overview of this work.  In particular, the accomplishments in 
the development of cell-instructive microenvironmental scaffold cues and soluble factor 
cues will be covered.  In addition, further studies contributing to the development of 
integrated tissue engineering approaches will also be proposed.      
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8.1 Development of 3D cell-instructive microenvironmental scaffold cues 
In this work, we modified the microenvironmental scaffold cues of collagen-based 
scaffolds through various approaches.  This approaches included (i) covalent cross-
linking of collagen scaffold to increase bulk stiffness (chapter 4), (ii) MMP-1 degradation 
of covalently cross-linked collagen scaffold to decrease bulk stiffness (chapter 5), and (iii) 
regulation of collagen fiber stiffness and rigidity through control of thermodynamic 
driving force during collagen self-assembly (chapter 6).  Following the various 
modifications, we further characterized the modified scaffolds in terms of the scaffolds’ 
mechanical properties, permeability, cytotoxicity and microstructures.  Through these 
characterizations, we were able to ensure that the ranges of stiffness achieved through the 
various modification methods were physiologically relevant.  We also checked that 
modified scaffolds possessed good permeability and were non-toxic to encapsulated cells.    
With the covalently modified scaffolds which were further degradable by MMP-1, 
we successfully controlled the malignancy of encapsulated HCC, characterized by 
significant differences in the cells’ morphology, liver-specific activities and in vivo 
angiogenic capacity.  The collagen scaffolds with varied fiber thickness and rigidity also 
allowed the regulation of fibroblast activation state, characterized by the differences in 
fibroblast morphology, actin levels and contractile activity of the cells.     
While the effect of stiffness on cell phenotypes had been demonstrated in several 
previous studies, majority of the earlier studies were carried out in the 2D culture 
configuration.[6, 38, 46]  As it had become apparent that cell-adhesion and signaling 
were significantly modified by the culture format, there is now general agreement that the 
2D configuration might not be representative of in vivo conditions.[7]  Although 
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emerging efforts in 3D control of stiffness had been described in several other studies, 
many of these works did not include such extensive characterizations of scaffold 
properties as presented in this work.  These characterizations were essential to ensure that 
the scaffold modifications did not result in the unintended alteration of cell viabilities and 
cellular activities.  
Furthermore, in the earlier studies, there was also no distinction between bulk and 
local stiffness when discussing scaffold material properties.  Through our fabrication of 
scaffolds with different microstructures, we also demonstrated that apart from the overall 
stiffness of 3D scaffolds, the microstructures and local stiffness of the scaffolds played 
very important roles in regulating cell activities.  This could be explained by the varied 
engagement of integrin with changes in gel microstructures.  Hence, it is essential to 
consider these key factors when discussing 3D cell culture scaffolds in the future.    
Overall, the different approaches for scaffold modification enabled us to generate 
distinct cell-instructive cues to bring about diverse phenotypic changes in various cell 
types.  Although we only examined collagen-based scaffolds in this study, the approaches 
could also be readily adapted to other self-assembling materials such as fibrin.  Such cell-
instructive scaffolds will be highly useful as models to understand the emergent behavior 
of stem cells, cancer cells and other cell types.  Owing to the promoting properties of the 
collagen-based scaffolds, they will also be very useful as cell-instructive and cell-
supporting scaffolds when implanted or injected in injured tissues or organs. 
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8.2 Design of novel delivery vehicles to regulate soluble cell-instructive cues 
For the second part of this work, we fabricated stiff and metastable PEGDA-PEI 
hydrogels for the release of cytokines and drugs in vivo.  The high stiffness of the 
material, attained from the highly branched architecture of PEI, allowed the hydrogel to 
release encapsulated substances independent of local tissue pressures.  The decoupled 
control of degradation rate was achieved by tuning the number of protonated amine 
groups of the hydrogel.   
Following synthesis, the hydrogel was extensively characterized in terms of its 
mechanical properties, degradation, cytotoxicity, in vitro and in vivo drug release.  This 
hydrogel system was also successfully used as an injectable GCSF delivery system, 
enabling sustained mobilization of stem and progenitor cells into circulation.  We expect 
that the degradation rates of the hydrogels developed in this study may be further 
controlled over a broader range by altering the precursor mass fractions and chemical 
modification of PEI.  These modifications can be made to suit different delivery needs 
and applications.  Due to its injectability and ease of application, we believe this hydrogel 
can also be readily combined with cell-instructive scaffolds to generate integrated tissue 
engineering systems. 
8.3 Future developments 
Having developed the cell-instructive scaffolds, the next phase of this study can be 
to modify these scaffolds to provide cell-instruction to other cell types. This should be 
achievable by tuning different parameters such as cross-linking density and fiber 
diameter to match the target tissues.  The drug delivery vehicle formed from PEGDA and 
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PEI can also be modified to generate a variety of release windows for the release of other 
cytokines. 
In addition, the integration of both scaffold and drug delivery vehicles for 
integrated tissue engineering approaches can also be explored.  Due to the flexibility of 
the system, many possible applications can be devised.  For example, the encapsulation 
and delivery of endothelial cells may be coupled with the provision of pro-angiogenic 
growth factors such as VEGF and platelet-derived growth factor to improve the 
vascularization at an ischemic area.  Mesenchymal stem cells in suitable 3D cell-
instructive scaffolds can also be provided with various differentiation factors to promote 
the differentiation of the mesenchymal stem cells in situ. Such a strategy will be useful 
for the endogenous repair of damaged tissues and the restoration of lost tissue function.  
As this study only provided a preliminary examination of how scaffold and delivery 
vehicles can be customized to provide cell-instruction, there needs to be further 
investigations to optimize scaffold properties and delivery windows for each intended 
application.   
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